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Endocrinological responses are under tight physiological control in healthy 
animals, with homeostatic adaptions made for diet, exercise and illness. 
Transient adrenal dysfunction with inadequate cortisol production, known as 
relative adrenal insufficiency (RAI), is a major component of critical illness–
related corticosteroid insufficiency (CIRCI), which involves dysfunction of the 
entire HPA axis. Recognition and treatment of CIRCI improves human 
survival rates. Whereas a low-dose ACTH stimulation test appears to be the 
most sensitive method of diagnosing CIRCI in people, published doses for this 
test in horses were considerably higher, and the lowest dose of ACTH that will 
maximally stimulate the adrenal glands of horses was unknown. Critical illness 
is also associated with peripheral tissue insulin resistance and hyperglycaemia 
in many species, but insulin and glucose dynamics in spontaneously sick adult 
horses remains to be investigated.  
   The overall aim was to document changes in cortisol, ACTH, insulin and 
glucose in sick horses; determine if adrenal or pancreatic dysfunction occurred, 
and which parameters were correlated with non-survival. A secondary aim was 
to validate the low-dose ACTH stimulation test in healthy adult horses and 
neonatal foals and then determine if CIRCI could be identified in sick horses.  
    A dose of synthetic ACTH of 0.1 µg/kg in healthy adult horses and 0.25 
µg/kg in neonatal foals resulted in maximal adrenal stimulation. In sick horses, 
cortisol, ACTH and ACTH/cortisol ratios were higher in non-survivors at 
admission. ACTH/cortisol ratios were higher in horses with systemic 
inflammatory response syndrome (SIRS) and those with an ischemic 
gastrointestinal lesion, suggesting adrenal dysfunction. Although horses with 
ischemic lesions had higher basal cortisol, they failed to respond to ACTH 
stimulation, further indicating adrenal dysfunction. RAI/CIRCI was diagnosed 
in 21% of sick horses and is associated with a poorer prognosis. Horses 
presenting with hyperglycaemia and corresponding relative hypoinsulinemia 
(suggestive of endocrine pancreas dysfunction) had a worse prognosis. 
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Endokrina responser är strikt reglerade hos friska djur och anpassas efter diet, fysiskt 
arbete och sjukdom. Övergående binjuredysfunktion ger otillräcklig kortisolproduktion, 
sk ”relative adrenal insufficiency”, RAI. Detta spelar en viktig roll i sjukdomsrelaterad 
sekundär kortisolsvikt (”critical illness-related corticosteroid insufficiency”, CIRCI) där 
man har dysfunktion av hela HPA axeln. Identifiering och behandling av sekundär 
kortisolsvikt förbättrar överlevnaden inom humanvården. Lågdos ACTH-
stimuleringstest förefaller vara det känsligaste testet för diagnos, men publicerade doser 
för att utföra provtagning på häst har varit betydligt högre än vad som används på 
humansidan. Den lägsta dos ACTH som krävs för maximal stimulering av hästens 
binjure har hittills varit okänd. Allvarlig sjukdom är också associerad med perifer 
insulinresistens och hyperglykemi på flera djurslag, men mer information om insulin- 
och glukosmetabolismen hos sjuka hästar behövs.  
    Målet med studien var att dokumentera förändringar i kortisol, ACTH, insulin och 
glukos hos sjuka hästar, att fastställa eventuell förekomst av binjure- eller 
pankreasinsufficiens, samt att undersöka vilka parametrar som kan korreleras till sämre 
prognos för överlevnad. Målet var också att validera ett lågdos ACTH-stimuleringstest 
för användning på vuxna hästar och neonatala föl, och att fastställa om CIRCI kunde 
detekteras hos sjuka hästar.  
    Syntetiskt ACTH doserat till 0,1µg/kg åt friska hästar och 0,25µg/kg åt friska 
neonatala föl resulterade i maximal binjurestimulering. Hos sjuka hästar som provtogs 
vid ankomst till klinik var kortisol, ACTH, och ACTH/kortisol kvoten högre hos de 
hästar som inte överlevde. ACTH/kortisol kvoten var högre hos hästar med systemiskt 
inflammationsrespons syndrom (SIRS) och hos hästar med ischemiska tarmlidanden, 
vilket indikerar binjuredysfunktion. Hästar med ischemiska skador hade också högre 
basala kortisolhalter, men svarade dåligt på ACTH-stimulering vilket ytterligare 
indikerar binjuredysfunktion. RAI/CIRCI diagnosticerades hos 21 % av de sjuka 
hästarna och var associerat med sämre prognos. Hästar som kom in med hyperglykemi 
och samtidig relativ hypoinsulinemi (överensstämmande med dysfunktion av endokrina 
pankreas) hade en sämre prognos för överlevnad. 
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Endocrinological responses are under tight physiological control in the healthy 
animal, with homeostatic adaptions made for diet, exercise and illness. The 
“stress response” involves recognition of a stressful situation by the amygdala, 
release of corticotrophin releasing hormone (CRH) from the hypothalamus 
which acts on the pituitary gland to produce adrenocorticotrophin (ACTH), and 
adrenal gland release of cortisol. Cortisol helps to maintain the bodies’ fluid 
balance, blood pressure, increases blood glucose and suppresses the immune 
system. Physiologic balance is crucial, with excessive or inadequate cortisol 
being detrimental. With illness, it is expected that CRH, ACTH, cortisol and 
glucose would increase; however how the exact concentrations of respective 
hormones corresponds to a particular degree of illness is unknown. With 
prolonged critical illness and organ dysfunction, regulatory hormone 
concentrations may be inadequate to compensate for the systemic effects of 
illness. 
Systemic inflammatory response syndrome (SIRS) occurs due to increased 
release of inflammatory mediators (cytokines, lipid mediators, proteases, 
vasoactive peptides) and/or decreased production of anti-inflammatory 
substances, and can lead to shock, multiple organ damage and eventually 
death. Concentrations of inflammatory mediators such as tumour necrosis 
factor-α, interleukin-1, and interleukin-6 are increased. These suppress 
secretion of CRH and ACTH, cause ACTH resistance, and alter cortisol 
secretion and metabolism. Transient adrenal dysfunction and inadequate 
cortisol production is known as relative adrenal insufficiency (RAI) and is a 
major component of critical illness–related corticosteroid insufficiency 
(CIRCI), which involves dysfunction of the entire HPA axis, including tissue 
corticosteroid resistance. Approximately half of human high-risk critically ill 
patients have CIRCI. This condition can result in a protracted and excessive 
inflammatory response and is associated with increased morbidity and 
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mortality rates. Recognition and treatment of CIRCI dramatically improves 
human survival rates.  
    There are descriptions of CIRCI in dogs, cats and neonatal foals. It is not 
known if CRICI exists in critically ill adult horses. While it has been shown 
that high admission baseline cortisol concentrations are associated with non-
survival in equine colic cases, delta cortisol, ACTH/cortisol ratios, and 
hormonal dysfunction throughout hospitalisation have never been assessed in 
horses. Also, extensive adrenal haemorrhage and adrenocortical necrosis are 
common necropsy findings of critically ill horses.  
    Diagnosis of CIRCI involves identification of a high ACTH-to-cortisol ratio 
or low delta cortisol (difference between baseline and ACTH-stimulated 
cortisol concentrations).Prior to this work the lowest published dose used for 
ACTH stimulation tests in adult horses was was 250 µg/horse or 0.5 µg/kg. 
This choice of dose is probably based on the tradition from human medicine, 
where supraphysiologic doses of ACTH (250 µg) are administered to diagnose 
Addison’s disease (absolute adrenal insufficiency) in human patients. The 
lowest dose of ACTH that will maximally stimulate the adrenal glands of 
horses is unknown, but it seems that use of a low-dose (1-2 µg) ACTH 
stimulation test appears to be more sensitive at diagnosing CIRCI. 
    Peripheral tissue insulin resistance and hyperglycaemia occur secondary to 
sepsis or severe trauma in many species, and elevated blood glucose 
concentration has been associated with non-survival. Regulation of blood 
glucose concentration by intensive insulin therapy has improved survival in 
some human studies, but not in others. While experimental lipopolysaccharide 
infusions have been shown to induce peripheral tissue insulin resistance in 
horses, the insulin and glucose dynamics in spontaneously sick adult horses has 
yet to be investigated.  
    Since both RAI and CIRCI are associated with decreased survival in sick 
horses, the overall aim of this research was to develop methods for and testing 
adrenal function in foals and adult horses, in addition to the pituitary, adrenal 
and pancreatic responses to illness in hospitalized adult horses. 
1.2 Introduction 
1.2.1 HPA axis 
Stress from fear and excitement in healthy animals and inappetence, 
dehydration, trauma, pain, and the effects of inflammation such as hypotension, 
hypoxemia or fever in sick animals activates the HPA axis. The parvocellular 
neurons located in the paraventricular nucleus of the hypothalamus synthesize 
CRH, which is released into the portal system of the median eminence by 
neurosecretory nerve terminals and then binds to the CRH-1 receptor on the 
corticotropic of the pituitary gland (Belda et al., 2015; Keller-Wood, 2015). 
Factors shown to influence CRH secretion include inputs from the 
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suprachiasmatic nucleus of the hypothalamus and the pineal gland which result 
in HPA activation in a circadian fashion with highest concentrations of cortisol 
occurring in the morning and lowest in the evening (Belda et al., 2015; Keller-
Wood, 2015). In horses, ACTH is released in peaks occurring approximately 10 
times per hour (Alexander et al., 1996). Seasonal and geographic variations in 
ACTH concentration also occur in horses, with higher values observed in the 
autumn, requiring seasonal and geographic specific reference ranges (Cordero 
et al., 2012; Schreiber et al., 2012; Funk et al., 2011; Beech et al., 2009; 
Donaldson et al., 2005). In illness CRH secretion is also influenced by 
lipopolysaccharide, cytokines, brain-derived neurotropic factor, neurosteroids, 
γ-aminobutyric acid, glutamate, nitric oxide as well as via the negative feedback 
effect of glucocorticoids (Dembek & Toribio; Belda et al., 2015; Keller-Wood, 
2015). Corticotrophin-releasing hormone and arginine vasopressin stimulate 
release of ACTH from corticotropes in the pituitary pars distalis, and this is 
moderated by lipopolysaccharide, cytokines, nitric oxide and glucocorticoids 
during illness and trauma (Beishuizen & Thijs, 2003; Turnbull & Rivier, 1999). 
The relative influence of arginine vasopressin and CRH on ACTH secretion is 
species specific, but in health CRH is the most important pituitary secretagogue 
in horses based on an in vitro study (Evans et al., 1993). However in an 
endotoxin challenge model vasopressin was a greater stimulant of ACTH release 
than CRH (Alexander & Irvine, 2002). Other stimulators of ACTH secretion 
include oxytocin, angiotensin II and β-adrenergic agents. Β-endorphins, 
encephalin and somatostatin decrease ACTH release (Belda et al., 2015; Keller-
Wood, 2015).. In humans ACTH has a half-life of 10-15 minutes (Guyton & 
Hall, 1996). The pituitary gland is connected to the hypothalamus by the 
infundibular stalk. The anterior lobe (adenohypophysis) in horses wraps around 
the other two lobes, and is divided into the pars distalis and pars tuberalis. Cells 
in the pars distalis include corticotropes, somatotropes, gonadotropes, 
thyrotropes and lactotropes. The corticotropes synthesize and secrete ACTH, 
which is the main proopiomelanocortin (POMC) derived peptide (Guyton & 
Hall, 1996). The pars intermedia contains mainly melanotropes and becomes 
hypertrophied with pituitary pars intermedia dysfunction (PPID) due to loss of 
dopaminergic inhibition (McFarlane & Cribb, 2005) In the melanotropes 
POMC is mainly cleaved into α-melanocyte stimulating hormone, in addition to 
ACTH, β-endorphin and corticotropin-like intermediate peptide. The pars 
nervosa stores and releases arginine vasopressin and oxytocin that is produced 
in the hypothalamus (Guyton & Hall, 1996).  
The adrenal glands are composed of the medulla which consist of 
catecholamine secreting chromaffin cells. In response to sympathetic stimulation 
there is secretion of adrenaline, nor-adrenaline and dopamine (Guyton & Hall, 
1996). The adrenal cortex is composed of 3 zones. The innermost zona 
reticularis which produces sex steroids such as androgens, the zona glomerulosa 
which secretes the mineralocorticoid aldosterone in response to angiotensin-II 
as part of the renin-angiotensin-aldosterone system. Aldosterone secretion is 
also increased in response to changes in extracellular fluid osmolality and 
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hyperkalemia. The zona fasciculata is the middle layer of the adrenal cortex and 
secretes glucocorticoids (cortisol), which decrease CRH, vasopressin and ACTH 
secretion by negative feedback (Guyton & Hall, 1996). Cortisol increases 
gluconeogenesis, decreases glucose utilization, increases serum glucose and 
inhibits the effects of insulin. The HPA axis regulates homeostatic systems that 
modulate metabolism, thirst, electrolyte balance, blood pressure, pain, immunity 
and sexual behavior. It is also responsible for the stress response to external and 
internal factors that ultimately ensures maintenance of organ function and 
individual survival. Cortisol has a negative feedback on the hypothalamus and 
pituitary gland to inhibit CRH and ACTH release (Guyton & Hall, 1996).  
1.2.2 Cortisol synthesis 
The adrenal cortex has a limited storage of steroids. Steroidogenesis is regulated 
by ACTH in an acute rapid process as well as in a long-term chronic process. 
The G-protein-coupled melanocortin type 2 receptor binds ACTH to stimulate 
the transcription and translation of steroidogenic acute regulatory protein (StAR) 
(Miller & Auchus, 2011). Cholesterol is transferred from the outer to the inner 
mitochondrial membrane by StAR, where it is converted into pregnenalone 
which is a rate limiting step (Miller & Auchus, 2011). ACTH increases 
circulatory cholesterol uptake into the adrenal cortex, in addition to increasing 
transcription of genes encoding steroidogenic enzymes such as hydroxysteroid 
dehydrogenases and cytochrome P450 enzymes. Adrenocortical hyperplasia and 
hypertrophy is promoted by ACTH stimulated synthesis of insulin-like growth 
factor II, fibroblast growth factor and epidermal growth factor (Miller & Auchus, 
2011). Once pregnenalone is transported to the endoplasmic reticulum it is 
converted to progesterone which in the zona glomerulosa is converted to 
aldosterone, while in the zona fasciculata progesterone is converted to 17α –
hydroxyprogesterone and then cortisol. Pregnenalone can also be converted to 
17α–pregnenolone to 17α–progesterone and cortisol (Guyton & Hall, 1996).  
1.2.3 Cortisol availability 
A single point in time cortisol concentration may not be reflective of the 
overall severity of illness as cortisol metabolism and function may also be 
altered during critical illness. Cortisol in plasma is 90% bound to an alpha-
globulin called corticosteroid-binding globulin (CBG or transcortin) and 
albumin. Only 5-10% is in the free physiologically active form in healthy 
individuals. Elastase cleaves CBG, decreasing its affinity for cortisol and 
increasing the free cortisol fraction at sites of inflammation (Pemberton et al., 
1988). Also due to saturation of binding proteins any increases in cortisol 
greater than approximately 25 µg/dL in humans resulting in increases in the 
free fraction of cortisol. As hyperproteinemia is common in critically ill 
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patients this also will raise the unbound and biologically active form of 
cortisol.  
    Reduced cortisol degradation due to reduced expression and activity of 
cortisol metabolizing enzymes; (Boonen et al., 2013) renal dysfunction 
prolonging the half-life of circulating cortisol, and diminished concentrations 
of albumin and cortisol binding globin lead to increases in physiologically 
active free-cortisol, (Boonen et al., 2013; Hart et al., 2011; Hamrahian et al., 
2004) influence serum free and total cortisol concentrations and the 
effectiveness of glucocorticoid receptor binding. In normal humans the half-
life of cortisol is 60-90 minutes. In critically ill humans total serum cortisol 
was found to increase 2-3 times higher than that of healthy volunteers, while 
free cortisol concentrations increased 7-10 times (Khan et al., 2004). Although 
measurement of total cortisol may underappreciate the HPA response to illness, 
measurement of free cortisol is technically difficult and not routinely available, 
and showed no advantage to serum total cortisol in the prediction of disease 
severity or outcome in septic foals (Hart et al., 2011). During stressful states 
such as illness from inflammation, infection or trauma there is an increase in 
CRH and ACTH secretion, overriding cortisol negative feedback effects 
resulting in further elevations of cortisol ideally in proportion to the severity of 
illness (Guyton & Hall, 1996).  
1.2.4 Cortisol function 
Glucocorticoids have important roles in metabolism, the immune system and the 
cardiovascular system. Stress, cytokine release, tissue damage, hypoglycaemia, 
hypotension and hypoxia stimulate the secretion of cortisol (Guyton & Hall, 
1996). Cortisol stimulates muscle catabolism to liberate proteins and promotes 
gluconeogenesis to produce glucose from amino acids. Cortisol also increases 
the lipolytic effect of catecholamines (Guyton & Hall, 1996). Cortisol increases 
myocardial and vascular smooth muscle responsiveness to epinephrine and 
norepinephrine and enhances water excretion. In the absence of glucocorticoids 
these processes are impaired. Glucocorticoids have an important function in 
moderating the inflammatory cascade and are used commonly at 
pharmacological doses for their anti-inflammatory and immunosuppressive 
effects. They increase peripheral neutrophil counts and reduce peripheral 
lymphocyte, monocyte and eosinophil counts resulting in the classic “stress 
leukogram” (Guyton & Hall, 1996).  
1.2.5 HPA axis in horses 
Several studies have investigated the HPA axis in normal horses. Circadian 
rhythm exists in horses, with cortisol peaks between 0600 and 0900 hr and 
troughs between 1900 and 2300 hr, (Irvine & Alexander, 1994; Toutain et al., 
1988; Eiler et al., 1979a; Hoffsis et al., 1970) but this rhythm is obliterated by 
minor perturbation (Irvine & Alexander, 1994). Cortisol concentrations have 
 24 
 
been measured in exercising horses, (Marc et al., 2000; Golland et al., 1999; 
Jimenez et al., 1998; Lassourd et al., 1996; Ralston et al., 1988; Baker et al., 
1982; Snow & Rose, 1981; James et al., 1970), sick pregnant mares, (Santschi 
et al., 1991a) equine colic patients, (Mair et al., 2014; Hinchcliff et al., 2005; 
Hoffsis & Murdick, 1970) and normal, (Stewart et al., 2013; Wong et al., 
2009b; Rossdale et al., 1973) premature (Silver et al., 1984) and septic foals 
(Dembek et al., 2013; Wong et al., 2009a; Hart et al., 2011; Hurcombe et al., 
2008; Gold et al., 2007). 
    Horses are distinct from other domestic species in that they have a short 
period of pre-partum foetal endocrinological maturity (Silver, 1992). Although 
plasma ACTH concentrations normally increase over the last 10 days of 
gestation, foetal serum cortisol concentration remains low until 4-5 days before 
birth, then rises exponentially in the last 24-48 hrs prior to birth (Cudd et al., 
1995; Silver & Fowden, 1994). Cortisol concentrations in normal, term foals 
continue to rise immediately after birth, peaking within the first hour of life, 
(Silver & Fowden, 1994) and then decline to previous levels by 4-12 hrs after 
birth (Rossdale et al., 1982). The rise in foetal cortisol concentration is 
associated with a rise in foetal ACTH concentration, (Fowden & Silver, 1995) 
suggesting a mature HPA axis at birth in normal term foals (Rossdale et al., 
1982).  
1.2.6 Assessment of adrenocortical function 
The function of the adrenal gland is assessed by performing an ACTH 
stimulation test, in which exogenous ACTH is injected intravenously or 
intramuscularly and cortisol concentrations are measured before and after 
injection. A normal adrenocortical response involves an increase in cortisol 
concentration, while a state of absolute adrenal insufficiency is diagnosed by 
low basal cortisol concentrations and failure to elevate cortisol concentration 
post ACTH administration. 
1.2.7 Adrenal insufficiency 
Absolute hypoadrenocorticism in humans is known as Addison’s disease, and 
may be primary due to failure of glucocorticoid (and mineralocorticoid) 
production from adrenocortical dysfunction, or secondary from failure of 
ACTH production due to pituitary dysfunction. Addison’s disease is not 
uncommon in young to middle aged dogs, but has not been diagnosed in 
horses.  
1.2.8 Adrenal insufficiency and exhaustion in adult horses 
Transient adrenal insufficiency has been reported in a horse associated with 
long-term anabolic steroid administration, (Dowling et al., 1993) and in a 
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neonatal foal secondary to sepsis (Couetil & Hoffman, 1998). In contrast to 
dogs and humans, iatrogenic hypoadrenocorticism secondary to glucocorticoid 
therapy is uncommon in horses. Although not well described in the literature 
there are anecdotal reports of suspected adrenal exhaustion in over-trained 
racehorses. One study in racing thoroughbreds found that although cortisol and 
ACTH concentrations decreased as the fitness of the horses increased, the 
adrenal gland response to exogenous ACTH was not altered by training 
(Wilson et al., 1991).  Furthermore, low serum cortisol concentrations were not 
found in stressed racehorses with a history of poor performance (Baker et al., 
1982). Therefore evidence of adrenal insufficiency in racehorses is lacking. 
1.2.9 History of cortisol use in critical care patients insufficiency 
Corticosteroid use in sepsis was first published in 1951, where there was a 
documented reduction in complications post streptococcal infection in a cohort 
of patients with the use of cortisone (Hahn et al., 1951). There were other studies 
showing beneficial results in patients with typhoid and sepsis. However in 
studies using 30 mg/kg of methylprednisolone in severe sepsis, comparative 
studies either showed no benefit or increases in mortality (Rai et al., 2004). 
Thereafter the use of glucocorticoids was discouraged. Nonetheless, after studies 
in patients with meningitis and sepsis showed beneficial results with the use of 
corticosteroids, there has been renewed interest in their use for specific 
conditions at low dosages (Annane et al., 2002; de Gans & van de Beek, 2002).  
1.2.10 Activation and dysfunction of the endocrine system in critically ill 
patients  
Sepsis, septic shock, trauma and the systemic inflammatory response syndrome 
(SIRS) can have dramatic effects on endocrine function (Jarek et al., 1993). 
Stress from many sources, including illness, dehydration, pain, fever, 
hypotension, inappetance, hypoxemia and tissue trauma activates the HPA axis 
with sustained release of CRH from the hypothalamus, ACTH from the 
pituitary and cortisol from the adrenal cortex (Jimenez et al., 1998; Lassourd et 
al., 1996; Messer et al., 1995; Furr et al., 1992; Santschi et al., 1991a; Hoffsis 
& Murdick, 1970). Increases in circulating glucocorticoid concentrations are an 
essential component of the stress response, which is necessary for homeostasis 
during critical illness.  Cortisol concentrations have been shown to increase 
after a variety of stressors, and the response is typically proportional to the 
magnitude of the injury or disease process (Munck et al., 1984). Inflammatory 
cytokines such as TNF-α, interleukin1-β, and lipopolysaccharide increase 
AVP, CRH and ACTH mRNA expression and secretion (Gadek-Michalska et 
al., 2013). Experimental lipopolysaccharide administration results in increases 
in AVP, CRH, ACTH and cortisol concentrations (Gadek-Michalska et al., 
2013; Beishuizen & Thijs, 2003; Dadoun et al., 1998).  The acute adaptive 
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response of the HPA axis to stress is to release hormones from storage and 
upregulate hormone synthesis.  However, this can ultimately lead to 
consumption of precursors, or maximization of rate-limiting enzymatic 
reactions and homeostatic mechanisms becoming incapable of keeping up with 
demands. The consequence of inflammatory mediators and microorganism 
products can result in inappropriately low concentrations of vasopressin, 
reduced adrenal responsiveness to ACTH, euthyroid sick syndrome, 
hyperleptinemia, hyperglycaemia and insulin resistance (Gheorghiţă et al., 
2015). Endocrine organs can also be victims of the effects of SIRS and sepsis, 
with multiple organ dysfunction (MODS) causing irreversible damage to the 
pancreas, pituitary and adrenal glands as well as other organs.  
1.2.11 Relative adrenal insufficiency (RAI) and critical illness–related 
corticosteroid insufficiency (CIRCI)  
Although plasma cortisol and ACTH concentrations are expected to be high 
during acute illness, a loss of correlation between ACTH and plasma cortisol 
concentrations has been observed in critically ill human patients, (Moran et al., 
1994; Sibbald et al., 1977) and ACTH concentration as well as basal and 
ACTH-stimulated cortisol concentrations are often astonishingly low (Soliman 
et al., 2004). Inflammatory mediators also cause ACTH resistance and alter 
cortisol secretion and metabolism (Cooper & Stewart, 2003; Beishuizen & 
Thijs, 2001; Zaloga & Marik, 2001). A prolonged inflammatory condition can 
lead to a blunting of HPA activation leading to transient adrenal insufficiency 
with inadequate production of cortisol to meet the demands of the severity of 
illness which is termed relative adrenal insufficiency (RAI). This can progress 
to absolute adrenal insufficiency which may be transient or permanent. 
Adequate adrenocortical function is essential for patient survival, but there is 
still debate on what constitutes an appropriate HPA response to critical illness 
(Annane et al., 2018). Although absolute hypoadrenocorticism is rare in human 
ICU patients,  RAI is increasingly being identified (Beishuizen & Thijs, 2001; 
Jurney et al., 1987). In human ICU’s, RAI is commonly caused by sepsis and 
SIRS, (Zaloga & Marik, 2001) with inflammatory mediators released in 
response to illness suppressing the release of CRH and ACTH leading to 
impairment of cortisol synthesis. Severe thrombosis and haemorrhage of the 
adrenal glands can lead to RAI (Cooper & Stewart, 2003; Zaloga & Marik, 
2001). Haemorrhagic adrenal necrosis as a complication of severe sepsis is 
called Waterhouse-Friderichsen Syndrome and can result in severe adrenal 
insufficiency (Bornstein, 2009). Septic human patients have developed 
multiple endocrine failure with decreased production of ACTH, arginine 
vasopressin, thyroid hormones and growth hormone as the result of pituitary 
necrosis (Prigent et al., 2004). The encompassing term of critical illness–
related corticosteroid insufficiency (CIRCI) is characterized by dysfunction of 
any part of the HPA axis, altered cortisol metabolism, and tissue resistance to 
glucocorticoids. Dysregulation of the HPA axis involves crosstalk between the 
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CRH -ACTH- vasopressin pathways, and the immune and autonomic nervous 
systems. Limited recent studies have shown marked reduction in plasma 
clearance of cortisol during critical illness, due to suppressed expression and 
activity of cortisol-metabolizing enzymes in the kidneys and liver. Despite 
elevated cortisol concentrations during critical illness insufficient 
glucocorticoid alpha-mediated anti-inflammatory activity resulting in tissue 
resistance to glucocorticoids has been demonstrated (Annane et al., 
2018).Although some authors recommend replacing the older term of RAI with 
CIRCI, RAI is really a distinct subset of CIRCI involving adrenal dysfunction. 
As adrenal function is the most widely tested component of CIRCI the term 
RAI/CIRCI has been adopted when CIRCI is diagnosed due to adrenal 
dysfunction (Dembek & Toribio, 2018) Although tissue glucocorticoid 
resistance has been documented it  is difficult rarely measured in clinical 
patients. Compared with hypothalamic or pituitary dysfunction, adrenocortical 
failure is the most common clinically observed condition affecting the HPA 
axis in people and foals (Annane et al., 2018; Dembek & Toribio, 2018).  HPA 
axis dysregulation results in a diagnosis of RAI or CIRCI in ~30-45% of high 
risk critically ill humans, (Annane et al., 2002; Beishuizen & Thijs, 2001; 
Rivers et al., 2001; Soni et al., 1995; Moran et al., 1994; Sibbald et al., 1977) 
and is associated with increased morbidity and mortality.(Soliman et al., 2004; 
Rivers et al., 2001; Bollart et al., 1998; Sibbald et al., 1977)  Recognition and 
treatment of CIRCI dramatically improves survival (Soliman et al., 2004; 
Rivers et al., 2001; Bollart et al., 1998; Sibbald et al., 1977) 
1.2.12 RAI/CIRCI in horses – background to this work  
It is likely that CIRCI occurs in critically ill horses as in other species(Stewart, 
2006). Couetil reported transient RAI in a septic neonatal foal that was 
successfully treated with prednisone.(Couetil & Hoffman, 1998) . However 
prednisone has subsequently been shown to have very poor bioavailability in 
horses.(Peroni et al., 2002)) In the 1970’s and 80’s Rossdale, Silver, Fouden 
and Ousey studied prematurely and the effects of the HPA axis on the 
readiness for birth. They studied prematurely induced foals and found that they 
had low serum cortisol concentrations at birth (4-5 times lower than term 
Thoroughbred and term induced pony foals). These prematurely induced foals 
had no significant rise in cortisol concentration over the next 2 hours as seen in 
normal foals.(Rossdale et al., 1982; Nathanielsz et al., 1975) They also had an 
absolute neutropenia, low neutrophil to lymphocyte ratio (N/L) and a poor 
prognosis for survival (Rossdale et al., 1982). To diagnose RAI in these 
prematurely induced foals Rossdale used a high-dose (0.125 mg/foal) ACTH 
stimulation test and advocated this as a method of assessing maturity (Rossdale 
et al., 1982). He found that serum cortisol concentration in the term foals 
increased in response to ACTH, while no response was seen in the premature 
foals. The lack of response implied adrenal gland insensitivity to ACTH rather 
than lack of pituitary secretion of trophic hormone (Rossdale et al., 1982). At 
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the beginning of this century, Toribio postulated that RAI is present in horses 
with colic, enterocolitis, sepsis, endotoxemia and DIC (Toribio, 2004).    
    A hallmark of RAI in humans is hypotension despite appropriate fluid and 
pressor therapy (Annane, 2005; Pizarro et al., 2005).  In a study of 10 septic 
foals, Gold, Divers and Bain reported that the 3/10 foals that were non-
responsive to fluid therapy had extremely high single-sample ACTH 
concentrations with normal serum cortisol concentrations, suggesting 
dysregulation of the HPA axis. On the other hand, the 7/10 foals that were 
responsive to fluid therapy had elevated ACTH and cortisol concentrations, 
suggesting an appropriate HPA response to sepsis (Gold et al., 2007).  
    In hospitalized horses subjected to necropsy, extensive adrenal gland 
haemorrhage, venous thrombosis and adrenocortical necrosis are common 
findings (Jubb et al., 1985). The adrenal histopathologic lesions appear more 
severe in horses compared to other domestic species, and the adrenal gland is 
considered a “shock” organ for horses.  In a 20 year career, I have had two 
critically ill horses die unexpectedly and adrenal gland haemorrhage was 
reported at necropsy as the cause of death. Adrenal haemorrhage and necrosis 
could be an acute event or could progress over a period of time. As adrenal 
exhaustion is likely to occur over time it appears necessary to monitor the HPA 
axis periodically throughout the hospitalisation period and not just at 
admission.  
1.2.13 Diagnosis of adrenal dysfunction 
The function of the HPA axis can be assessed by comparing cortisol 
concentrations to plasma CRH and ACTH concentrations. A high 
ACTH/cortisol ratio can be used to diagnose hypothalamic-adrenal 
dysregulation indicating adrenal exhaustion, adrenal damage or inadequate 
cortisol production and release in response to high pituitary output of ACTH. 
This is considered as a primary hypoadrenal status where there is low plasma 
cortisol and high ACTH. Secondary hypoadrenalism is distinguished by low 
cortisol and ACTH concentrations due to pituitary dysfunction. Hypothalamic 
dysfunction is considered tertiary adrenal insufficiency. In foals, just as in 
people, primary adrenocortical failure is the most common cause of adrenal 
insufficiency. In 2 populations of septic foals, non-survivors had significantly 
higher ACTH/cortisol ratios than surviving foals (Hurcombe et al., 2008; Gold 
et al., 2007; Bousquet-Melou et al., 2006).  High ACTH concentrations and 
low corresponding cortisol concentrations, suggest HPA dysfunction at the 
level of the adrenal gland, and therefore RAI.  
1.2.14 Diagnosis of RAI and CIRCI in humans 
Changes in plasma electrolyte concentrations or identification of peripheral 
blood eosinophilia as indicators of adrenal hypofunction lack sensitivity and 
specificity. Evaluation of adrenal function in critically ill patients relies on 
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either measurement of basal cortisol concentration or dynamic tests such as the 
ACTH stimulation test, metapyrone test, insulin hypoglycemic test or the CRH 
stimulation test. In normal humans resting cortisol concentrations are 10-20 
µg/dL. The maximum stress induced cortisol in humans is approximately 60 
µg/dL (Annane et al., 1998).  Mean basal cortisol in surviving human ICU 
patients were 27 µg/dL, compared to 47 µg/dL in non-survivors (Rothwell & 
Lawler, 1995). Others have found mean cortisol in human patients with septic 
shock to average 50 µg/dL (Marik & Zaloga, 2002).  Due to the wide ranges of 
cortisol concentrations and severities of illness it is difficult to determine a 
concentration of cortisol that is adequate for every clinical situation. This is 
reflected in the reported incidences of adrenal insufficiency in critically ill 
patients which varies from 1.5-75% (Rai et al., 2004). Although a single factor 
should never be used to prognosticate survival, a clear relationship has not 
been demonstrated between serum cortisol and mortality in critically ill 
patients (Rai et al., 2004). 
    There is still a lack of consensus, even among a panel of experts, as to the 
best methods to diagnose CIRCI in humans (Annane et al., 2018).  Marik 
suggested that random cortisol concentrations < 25 µg/dL in highly stressed 
patients was useful to diagnose adrenal insufficiency and substantiate 
hydrocortisone therapy (Marik & Zaloga, 2003). The European CIRCI 
guidelines suggest using either a random endogenous cortisol of < 10 µg/dL (or 
a delta-cortisol of < 9 µg/dL after intravenous administration of 250 µg 
cosyntropin, which is the high-dose ACTH stimulation test) (Annane et al., 
2018). It can also vary dramatically throughout patient admission, resuscitation 
and over hospitalisation.  
    The insulin-induced hypoglycemic test is considered the gold standard to 
diagnose HPA dysfunction in humans. The administration of exogenous insulin 
results in hypoglycemia which is a potent stimulator of the HPA axis, therefore 
post insulin ACTH and cortisol are measured. However, the test is 
contraindicated in critically ill people due to glucose dysregulation that is often 
simultaneously occurring. The metyrapone test works by inhibition of 
adrenocortical 11 –βhydroxylase, which converts 11-deoxygotisol to cortisol. 
In normal individuals, the induced reduction in cortisol concentrations 
stimulates CRH and ACTH release and increases adrenocortical 
steroidogenesis and 11-deoxygotisol accumulation (Marik, 2009). A CRH 
stimulation test can also be performed to assess the pituitary adrenal response 
(secondary hypocortisolemia). 
1.2.15 High dose and low physiological dose ACTH stimulation tests 
Traditionally, to diagnose absolute adrenal insufficiency (Addison’s disease), 
supra-physiological doses of ACTH were administered, e.g. 250 µg /human 
patient or ~2-5 µg/kg. However, in critically ill human patients, a normal 
response to this dose does not rule out RAI.  RAI is believed to be due, in part, 
to adrenal resistance to ACTH. In humans, administration of 250 µg of ACTH 
 30 
 
(100-fold greater than endogenous stress-induced ACTH levels (Oelkers, 1996) 
can override adrenal resistance to ACTH, resulting in a normal cortisol 
response, thus falsely ruling out a diagnosis of RAI. In human medicine, the 
physiologic low-dose (1-2 µg/patient) ACTH test appears more sensitive at 
diagnosing early/mild cases of adrenal suppression, and accordingly, has been 
recommended by some sources to replace the conventional 250µg test for 
identification of adrenal insufficiency in humans (Gonc et al., 2003); 
Beishuizen et al., 2000) including premature infants (Nykanen et al., 1999). 
One randomized trial showed that the low-dose (1 µg) ACTH test was better 
able to predict the longer duration of vasopressor dependence and the 
hemodynamic response to hydrocortisone in septic shock patients than the 
high-dose ACTH test or a random basal cortisol < 25 µg/dL, in extremely ill 
people with a mortality rate of 47% (Marik & Zaloga, 2003).  A prospective 
study with 74 septic shock patients showed that the high and low-dose ACTH 
stimulation tests were equally accurate in predicting dependency on 
vasopressors and mortality (Moraes et al., 2012). 
    There is still a lack of consensus, even among a panel of experts, as to the 
best methods to diagnose CIRCI in humans (Annane et al., 2018). The 
European CIRCI guidelines suggest using either a random endogenous cortisol 
of < 10 µg/dL or a delta-cortisol of < 9 µg/dL after intravenous administration 
of 250 µg cosyntropin (high-dose ACTH stimulation test) (Annane et al., 
2018). The main reason given for utilizing the high-dose ACTH stimulation 
test over the low-dose ACTH stimulation test for critically ill humans was 
simply that of convenience as the low-dose test requires dilution of the ACTH 
and calculation of an appropriate volume, while in a high dose test the entire 
250 µg vial of ACTH is injected. The high dose test is efficacious and 
considered safe, even to perform on critically ill neonates, with the transient 
cortisol release considered of little consequence (and potential benefit) to the 
patient. However, in veterinary practice where the expense of diagnostic 
procedures is often the main limiting factor limiting their use, a low dose 
ACTH stimulation test would be significantly cheaper to perform than a high 
dose ACTH stimulation test. Although most studies show it is equally sensitive 
in diagnosing adrenal RAI in critically ill patients, there is also some evidence 
to suggest it is more sensitive at diagnosing adrenal dysfunction in this group 
(Moraes et al., 2012; Marik & Zaloga, 2003).  
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1.2.16 Studies of the HPA axis in sick neonatal foals 
Several recent studies have investigated the HPA axis in sick and septic foals 
(Dembek et al., 2013; Wong et al., 2009a; Hurcombe et al., 2008; Gold et al., 
2007; Hart et al., 2007). Adrenal dysfunction has been identified in septic 
neonatal foals by the use of a low-dose ACTH stimulation test (Hart et al., 
2009b; Wong et al., 2009a).  No significant differences in peak or delta cortisol 
response were detected between groups of ill and age-matched healthy foals in 
response to a low-dose ACTH stimulation test (0.1 μg/kg IV) (Wong et al., 
2009a) or to a paired low-dose (10 μg IV)/high-dose (100 μg IV) ACTH 
stimulation test (Hart et al., 2009b). However, when human diagnostic criteria 
for CIRCI were utilized, approximately 50% of all hospitalized foals and 
approximately 40% of septic foals met these criteria (Hart et al., 2009b).  Non-
surviving foals had significantly lower cortisol responses to low-dose ACTH 
stimulation as compared to survivors (Wong et al., 2009a). Foals that had an 
inadequate cortisol response to a high-dose ACTH stimulation test had a 
significantly greater incidence of shock, multiple organ dysfunction syndrome, 
and non-survival than foals with an adequate cortisol response to ACTH (Hart 
et al., 2009b).   
1.2.17 Determination of HPA axis in sick adult horses 
Cortisol concentrations have been measured in sick pregnant mares, (Santschi 
et al., 1991) equine colic patients (Mair et al., 2014; Ayala et al., 2012; 
  
Figure 1a.      Figure 1b. 
 
Figure 1a.  Septic neonatal foal receiving intensive care  
Figure 1b.   Foal with botulism receiving positive pressure ventilation 
Photos: A.J. Stewart. 
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Hinchcliff et al., 2005; Hoffsis & Murdick, 1970). Sparse information is 
available for about ACTH concentrations in adult horses in association with 
illness (Mair et al., 2014; Ayala et al., 2012). Sick animals should have higher 
cortisol concentrations than healthy animals, but it is unknown what an 
appropriate stressed cortisol concentration should be with various severities of 
illness in horses.  To simulate a physiologically stressed basal cortisol, Hart  
used the lowest (mean – 1 SD) cortisol concentration obtained after 
administration of cosyntropin to healthy foals to define a cut-off value for an 
appropriate basal cortisol concentration in sick foals (Hart et al., 2009b). As 
adrenal exhaustion is likely to occur progressively over time it is highly 
relevant, as done in this thesis work to monitor the HPA axis periodically over 
the duration of hospitalisation.  Serial monitoring of HPA function is 
frequently recommended but rarely performed and never reported in critically 
ill veterinary species. There are many studies that have performed ACTH 
stimulation tests at admission, (Wong et al., 2009a; Martin et al., 2008; Burkitt 
et al., 2007) but to the authors knowledge there are no veterinary studies that 
have performed ACTH stimulation tests repeatedly throughout hospitalisation. 
Although many patients improve rapidly with intensive care, the effects of 
prolonged stress of severe illness, adrenal exhaustion or adrenal haemorrhage 
and necrosis may result in the development of RAI during the period of 
hospitalisation that was not identified during a single sample test at admission 
to the ICU. Cortisol concentrations are often remarkably (and appropriately) 
high at admission in equine colic patients, (Mair et al., 2014; Hinchcliff et al., 
2005) yet after several days of critical illness, hypothalamic and adrenal 
function may well be severely compromised. Sequential monitoring, especially 
in patients that are not rapidly improving is therefore warranted. 
  
Figure 2a.                Figure 2b. 
 
Figure 2a. Exploratory laparotomy being performed on an anaesthetised horse in dorsal 
recumbency. 
Figure 2b. Ischaemic small intestine secondary to a strangulating lipoma from the horse 
undergoing exploratory laparotomy 
Photos: A.J. Stewart. 
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1.2.18 Treatment of RAI 
Although septic patients do not benefit from a short course of supra-
physiological doses of corticosteroids, (Bone & Fisher, 1987) results of several 
recent randomized controlled trials in humans, indicate that administration of 
physiological doses can reduce the mortality associated with septic shock 
(Annane, 2001). In human patients diagnosed with RAI, a marked 
improvement in survival occurred after subsequent treatment with low “stress” 
doses of glucocorticoids (Annane et al., 2002; Rivers et al., 2001; McKee & 
Finlay, 1983). Moreover, glucocorticoid therapy does not increase the 
complication rate compared to placebo (Annane et al., 2002). 
    Premature foals that have experienced in utero stress have a higher N/L ratio 
and a better prognosis for survival than prematurely delivered foals. 
Experimental direct administration of CRH, ACTH or betamethasone to the 
foetus in utero using ultrasound guided intramuscular injections in the last 
month of gestation resulted in increased foetal cortisol and elevated maternal 
progesterone levels consistent with foetal adrenal gland maturation. This 
procedure is not without risk and did result in abortion in a subset of mares. 
Multiple injections of depot corticotropin1-24 to pregnant mares at risk of 
premature delivery as well as postpartum administration to premature foals 
appears to hasten hormonal maturity, but is still under investigation.(Silver & 
Fowden, 1994) In human patients diagnosed with RAI low dose of 
hydrocortisone (50-300 mg per day) over 5-7 days resulted in clinical 
improvement and increased survival (Annane, 2001). Recognition and 
treatment of CIRCI in human patients substantially improves the survival rate 
(Annane, 2005; McKee & Finlay, 1983).   
1.2.19 Insulin and glucose regulation 
The β cells of the endocrine pancreas are responsible for the synthesis and 
release of insulin, which is the main mammalian anabolic hormone. Insulin 
regulates carbohydrate and lipid metabolism by increasing glucose uptake from 
the blood to insulin sensitive tissues including skeletal muscle, adipose tissue 
and the liver. High circulating insulin concentrations promote the transformation 
of glucose into glycogen through the process of glycogenesis in the skeletal 
muscles and liver, or into triglycerides through lipogenesis in the adipose tissue 
and liver. There is a balance between glucose and insulin concentrations, with 
low of circulating insulin concentrations resulting in an increase in hepatic 
glucose secretion by promotion of gluconeogenesis and glycogenolysis 
(Sonksen & Sonksen, 2000).  
1.2.20 Insulin resistance and the critically ill patient 
Insulin resistance is defined as the failure of tissues to respond to endogenous or 
exogenous insulin, which results in uncontrolled hyperglycaemia (van den 
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Berghe et al., 2001). Insulin resistance develops through several mechanisms at 
the cellular level. Cellular hypoxia results in decreased availability of the insulin 
receptor and oxidative stress leads to activation of inflammatory pathways and 
inhibition of post-receptor insulin signalling pathways. 
In human patients with sepsis or severe trauma, peripheral tissue insulin 
resistance and hyperglycaemia are common. High blood glucose concentrations 
are associated with an increased risk of death and poor outcome (Griesdale et 
al., 2009; Arabi et al., 2008; van den Berghe et al., 2001). Tight control of blood 
glucose concentrations between 80 – 110 mg/dL through intensive insulin 
therapy was associated with improved survival in critically ill patients (van den 
Berghe et al., 2001). In contrast,  results of other studies have demonstrated that 
intensive insulin therapy results in significant increases in the risk of 
hypoglycaemia, and is associated with poor survival, resulting in no overall 
change in mortality (Macrae et al., 2014). Still other studies have shown that less 
stringent conventional glucose regulation, such as between 140 – 180 mg/dL 
through insulin infusions resulted in a decreased incidence of hypoglycaemia 
without an increase in mortality (Griesdale et al., 2009; Preiser et al., 2009; 
Arabi et al., 2008). Guidelines suggest that cautious insulin therapy may be 
appropriate for critically ill patients.(Jacobi et al., 2012)  
1.2.21 Hyperglycaemia in sick horses and after lipopolysaccharide 
administration 
Hyperglycaemia is common in horses with colic and is associated with non-
survival (Hassel et al., 2009; Hollis et al., 2007). In the early stages of systemic 
inflammation, low serum insulin and increased insulin sensitivity has been 
shown in several studies involving horses (Tadros et al., 2013b; Barsnick et al., 
2011; Barsnick et al., 2010; Vick et al., 2008). Tadros demonstrated decreases 
in insulin concentrations after lipopolysaccharide administration, suggesting that 
the resultant hyperglycaemia was from pancreatic dysfunction and peripheral 
insulin resistance (Tadros et al., 2013). Little was known about insulin and 
glucose dynamics in adult critically ill horses and if insulin resistance or 
pancreatic dysfunction occurred in naturally occurring disease. 
1.2.22 Measurement of hormone concentrations 
Liquid chromatography and high-resolution/high-accuracy mass spectrometry 
(LC-MS) are the gold standards to measure hormone concentrations. Although 
useful in a research setting LC-MS is not utilized for clinical cases due to the 
requirement of sophisticated equipment and specialised technical skills and the 
time involved in sample analysis. Since there are no equine specific cortisol, 
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ACTH or insulin standards or antibodies,  all commercially available assays will 
likely underestimate equine hormones compared to LC-MC. 
Radioimmunoassays (RIA), chemiluminescent immunoassays (CLIA) and 
enzyme-linked immunosorbent assays (ELISA) designed for use on human 
samples have been utilized for equine samples with variable levels of validation, 
co-efficients of variation, precision and accuracy. The RIA had been considered 
as the “gold standard”; however, because of the use of radioactive reagents, the 
tests becoming less popular. When concentrations of various hormones are 
measured using different analytical methodologies, it is difficult to directly 
compare actual values obtained in different studies. References ranges 
established at one laboratory may not be appropriate for another, especially when 
different assays are utilized.  
Even using human samples, there is concern regarding the variations in 
precision and accuracy of cortisol assays. The co-efficient of variation between 
cortisol assays can vary by approximately 10-12% (Rai et al., 2004). When one 
sample is submitted to multiple laboratories various assays can provide 
significantly different results (Clark et al., 1998). In humans with septic shock 
immunoassays for total cortisol also appear to correlate poorly (inter-assay 
variations in up to 27% of cases), when compared to the gold standard of liquid–
chromatography mass spectrometry (LC-MS) (Bornstein, 2009; Briegel et al., 
2009). Although there are limitations in the use of immunoassays to measure 
cortisol and ACTH concentrations, standardized sample handling procedures for 
samples and looking at trends and relative changes in hormone concentrations 
measured on same assay from the same institution are likely to be valid. The 
ELISA has been used in many research projects for measurement of insulin, but 
the test uses porcine standards and provides lower insulin values than the RIA. 
The CLIA is commonly used in both clinical and research settings; but the assay 
is based on human cortisol, insulin and ACTH.  
Although equine cortisol concentrations are fairly consistent between 
different assays, measurement of equine ACTH1-39 has shown many 
inconsistencies between assays. In a large study in normal and PPID horses, 
Banse et al, found poor agreement when comparing one particular 
radioimmunoassay (RIA kit, Biomedicals, Orangeburg, NY) with the 
chemiluminescent Immulite™ assay with large discordance between 
results.(Banse et al., 2018) In a smaller study evaluating 39 plasma samples from 
normal and PPID-affected horses, when evaluating the Scantibodies™ 
immunoradiometric kit compared to various other radioimmunoassays and the 
chemiluminescent Immulite™ assay, Schott et al found fairly good correlation 
between the Scantibodies™ and Immulite™ assays. However the Immulite™ 
yielded ACTH concentrations 3.6-fold greater than the Scantabodies™ assay, 
with Bland-Altman analysis revealing bias ± limits of agreement of 24.2 ± 62.9 
between these two assays. There was a positive bias of the Immulite™ 
increasing with increasing ACTH concentrations in PPID horses (Schott, 2013). 
As ACTH1-39 produced in times of stress originates from the corticotropes of the 
pars distalis, rather than pars intermedia melanotrope derived ACTH in PPID-
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affected horses, where incomplete ACTH fragments and other pro-
opiomelanocortin (POMC) derived peptides may be measured as ACTH, the 
consequences of studies comparing assays of immunoreactively measurable 
ACTH may not be as of great a consequence in sick horses compared to PPID-





The overall aim for this thesis was to study factors that influence cortisol and 
ACTH dynamics and insulin and glucose dynamics in sick adult horses after 
validating the ACTH stimulation test in adult horses and neonatal foals. 
 
The specific objectives were: 
 
 To validate the ACTH stimulation test in adult horses and neonatal 
foals. 
 
 To determine the lowest ACTH dose that would consistently induce a 
significant increase in cortisol concentration in healthy adult horses 
and neonatal foals. 
 
 To determine the lowest ACTH dose required to induce a maximum 
increase in cortisol concentration and to identify the time to peak 
cortisol concentration after administration of low doses of ACTH.  
 
 To determine the effect of administration of low doses of ACTH on 
haematologic values in healthy adult horses and neonatal foals. 
 
 To describe the glucose and insulin dynamics in horses diagnosed with 
SIRS and evaluate their usefulness as predictors of survival. 
 
 To determine if ACTH and cortisol concentrations, and the 
ACTH/cortisol ratio vary with survival, presence of SIRS or ischemic 
gastrointestinal lesions at admission, or throughout hospitalisation. 
 
 To determine if sick horses had inappropriately low cortisol 
concentrations before and after an ACTH stimulation test. 






This section provides a brief summary on materials and methods used in the 
separate studies (I – V) included in this thesis. More detailed descriptions are 
found in each of the papers. 
3.1 Horses 
All aspects of studies I and II were approved by the Auburn University 
Institutional Laboratory Animal Care and Use Committees (20040744). The 
adult horses and the majority of foals used in the studies were owned by the 
Department of Clinical Sciences (Figure 3a), College of Veterinary Medicine, 
Auburn University, Auburn, Alabama, USA. Some foals were client owned and 
were lent to me for the purpose of sampling for this project. 
    All aspects of the studies III - V were approved by the Auburn and Colorado 
State Universities Institutional Laboratory Animal Care and Use Committees 
(20091564, 09-079A-01) and the College of Veterinary Medicine Clinical 
Research Review Committee, with signed owner’s consent obtained for ACTH 
stimulation tests. The dose of ACTH used on the sick horses was 0.1 µg/kg 
which is less than the high dose of 250 µg/patient that is routinely administered 
to critically ill human patients, including septic infants. The transient rise in 
cortisol concentrations induced are not considered detrimental in any manner 
and there have been no side effects reported from the test. The horses were 
privately owned patients admitted on an emergency basis to the John Thomas 
Vaughan Large Animal Teaching Hospital, College of Veterinary Medicine, 
Auburn University, USA and Colorado State University, College of Veterinary 
Medicine & Biomedical Sciences, Fort Collins, USA. Information provided to 
clients regarding horse enrolment is included in appendix 1. The client consent 
form is in appendix 2.   
    Horses with clinical signs of Equine Metabolic Syndrome (EMS) and PPID 
were excluded from each study. Horses and foals in studies I and II were deemed 
to be clinically healthy based on history, physical examination findings, and 
results of a complete blood count (CBC), serum biochemical profile and 
3 Comments on materials and method 
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fibrinogen concentration. No horse had received any medication in the preceding 
2 months. 
    For projects III – V sick horses presenting to the equine emergency service of 
two university teaching hospitals (Auburn University and Colorado State 
University) over two summers (May to August) were enrolled (Figure 3b). For 
project III only horses ≥ 5 years that were diagnosed with SIRS were included, 
while in studies IV – V horses ≥ 1 year were included. Data recorded included 
signalment, clinical examination findings and routine admission bloodwork 
(haematological and biochemical data); diagnosis and duration of 
hospitalisation.  
For sick horses blood was drawn through an intravenous catheter placed for the 
purposes of treatment. The study had no influence on clinical decisions or 
treatments administered to patients.  
3.2 Study designs 
3.2.1 Study I 
One of the previous difficulties in trying to diagnose RAI in horses was that the 
ideal dose of ACTH required for ACTH stimulation testing was unknown.  
Therefore, we performed a study to determine the lowest dosage of ACTH 
 
Figure 3a.               Figure 3b. 
 
Figure 3a. University owned brood mare and foal used in project III and later adopted as a 
potential sport horse.  
Figure 3b. Client owned horse in the equine intensive care unit receiving intravenous fluids after 
having 2 meters of small intestine removed surgically the previous evening. 


















required to produce a significant increase in cortisol concentrations in normal 
adult horses (Stewart et al., 2011). In a randomized crossover design, 5 ACTH 
stimulation tests were performed on each of 8 horses (4 mares and 4 geldings), 
with a 3-day wash-out period between tests. Four dosages (0.02, 0.1, 0.25 and 
0.5µg/kg) of cosyntropin and saline as a negative control were administered IV 
into a jugular vein. Blood samples were collected before (0 minutes [baseline]) 
and 30, 60, 90, 120, 180, and 240 minutes after injection of cosyntropin or saline 
solution for measurement of serum cortisol at each time point and plasma ACTH 
at baseline. Complete blood counts were performed with an automated analyser 
(Advia 120 Haematology System, Siemens, Tarrytown, NY.) and differential 
cell counts were performed by hand at 0, 60, 120, and 240 minutes after injection 
of cosyntropin or saline solution for routine CBCs. 
3.2.2 Study II 
Eleven apparently healthy foals (6 colts and 5 fillies) were studied. All foals 
were full term (> 330 days gestation), born without assistance and had an 
immunoglobulin concentration (> 800 mg/dL or < 8 g/L) by 24 hours of age.  
Foals entered the study at 2 days of age and were 12 days of age by study 
completion. No foal had received any medication prior to the study except 
diazepam and butorphanol for placement of a central venous catheter the day 
prior to study commencement (Figure 3c). The foals weighed from 32 to 65 kg; 
52 ± 11 kg at the commencement of the study and were weighed daily during 
the study. Foals gained 4.5 to 29 kg13 ± 7 kg by the end of the study. In a 
randomized crossover design, 5 ACTH stimulation tests were performed on each 
foal, with a 2-day washout period between tests. For each test, saline (0.9% 
NaCl) solution or 1 of 4 doses (0.02, 0.1, 0.25, and 0.5 µg/kg cosyntropin was 
administered IV into the contralateral jugular vein via a transiently placed 
catheter. Blood samples were collected from the central venous jugular catheter 
immediately before (0 minutes [baseline]) and 30, 60, 90, 120, 180, and 240 
minutes after injection of cosyntropin or saline solution for measurement of 
cortisol concentration each time point and plasma ACTH at baseline. Samples 
were also collected at 10 and 20 minutes in 6 of 11 foals for cortisol 
measurement. Blood was also collected before and 60, 120, and 240 minutes 





3.2.3 Study III 
To investigate insulin dysregulation in horses with SIRS a subset of horses used 
in study IV that presented to the emergency service of the Auburn University 
J.T. Vaughan Large Animal Teaching Hospital that fit additional criteria of 
being > 5 years of age and diagnosed with SIRS were included.  Serum insulin 
and glucose concentrations were measured at admission from archived frozen 
serum samples. Insulin concentrations were measured in duplicate using an 
radioimmunoassay and blood glucose was measured using a glucohexokinase 
colorimetric assay as previously described (Reimers et al., 1982),(de Laat et al., 
2016). Horses were grouped by outcome (survival, hyperinsulinemia and 
hyperglycaemia). 
3.2.4 Study IV  
To determine the cortisol and ACTH concentrations and ACTH/cortisol ratios 
in sick horses throughout hospitalisation and any associations with survival, an 
ischemic gastrointestinal lesion and SIRS. One hundred and fifty-one horses (> 
1 year of age) presenting to the emergency service of two university teaching 
hospitals (Auburn University and Colorado State University) were recruited over 
two summers (mid-May until mid-August) and serum cortisol and plasma 
ACTH concentrations measured at admission and on morning of days 2, 4 and 6 
if the patient was still hospitalized. Data recorded included signalment, physical 
examination findings and routine bloodwork at admission (haematological and 
biochemical data); diagnosis, outcome, duration of hospitalisation, diagnosis of 
SIRS, SIRS score (see below) and presence of an ischemic gastrointestinal lesion 
 
Figure 3c. Placing a central venous catheter in a heavily sedated 1 day old foal for later 
collection of blood samples 
Photo: A.J. Stewart. 
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for horses that underwent surgery or necropsy. For statistical analysis horses 
were grouped by outcome (survival, SIRS score, presence of SIRS, SIRS score 
and an ischemic lesion).  
3.2.5 Study V  
To identify adrenal dysfunction in critically ill adult horses, a subset of 58 
patients enrolled for project IV were requested to be involved in ACTH testing. 
Within the first 2 hours of admission, blood was collected for baseline 
endogenous serum cortisol and plasma ACTH concentrations. A low dose 
ACTH stimulation test was then performed with administration of 0.1 µg/kg IV 
of previously diluted cosyntropin with blood was collected at 30 minutes (T = 
30) for post ACTH cortisol measurement, as previously described (Stewart et 
al., 2011). This sampling occurred at admission and on the mornings of days 2, 
4 and 6 if the patient was still hospitalized, having not been discharged or 
euthanized. Data recorded included signalment, physical examination findings 
and routine bloodwork at admission (haematological and biochemical data); 
diagnosis, outcome, duration of hospitalisation, diagnosis of SIRS, SIRS score 
and presence of an ischemic gastrointestinal lesion for horses that underwent 
surgery or necropsy. Criteria adapted from definitions utilized in human 
intensive care and in a study involving sick neonatal foals was used to define an 
inadequate adrenal response to the degree of illness (Annane et al., 2018; Hart 
et al., 2009b; Annane et al., 2006).  An inappropriately low basal cortisol 
concentration was defined by 2 methods: 1) a physiologic stressed cortisol 
concentration calculated as lowest cortisol concentration (mean - 1SD) obtained 
after administration of a physiologic dose (0.1 µg/kg) of  cosyntropin to healthy 
adult horses which calculates as an endogenous cortisol <9.7 µg/dL  and 2) a 
more conservative value of less than the lowest basal cortisol concentration 
(mean - 1SD) obtained from healthy horses, which calculates as < 4.51µg/dL 
(Hart et al., 2011; Stewart et al., 2011). An inappropriately low delta-cortisol 30 
minutes after the administration of 0.1 µg/kg of cortrosyn was defined by two 
methods: 1) a value less than the mean delta-cortisol obtained from healthy 
horses which was < 5.65 µg/dL (definition previously utilized in a study of 
neonatal foals) and a more conservative value less than the mean delta-cortisol-
1SD obtained from healthy horses which was < 4.15 µg/dL (Hart et al., 2011; 
Stewart et al., 2011). A horse was defined as having RAI/CIRCI if it had an 
inappropriately low basal or delta-cortisol and it was considered to be critically 
ill based on clinical parameters. Horses were grouped by outcome (survival, 
SIRS score, presence of SIRS and an ischemic lesion).  
3.3 Blood collection and sample handling 
Blood was collected through an aseptically placed intravenous catheter  (Figures 
4a-d) or by venipuncture and placed in a plain glass tube and a cold tube 
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containing EDTA mixed with 0.3 mL of the protease inhibitor aprotinin 
(lyophilized powder, USB Corp, Cleveland) with final concentration of 500 
kallikrein inactivator units/mL of blood (Kemppainen et al., 1994). Plasma was 
centrifuged within 20 minutes, while serum was collected by centrifugation after 
allowing the blood sample to clot for 45 minutes at room temperature. Samples 
were frozen at -80°C until assayed. 
 
 
Figure 4a                  Figure 4b 
  
Figure 4c                  Figure 4d 
 
Figure 4a Student assistants collecting blood from a jugular catheter on a sick horse for 
project III, IV or V 
Figure 4b Student assistant placing blood into plain and EDTA vacutainer tubes 
Figure 4c Client consent form, diluted cosyntropin and blood tubes in preparation for 
performing a low-dose ACTH stimulation test for project V.  
Figure 4d Student assistants collecting blood from a jugular catheter from a university owned 
research foal for project II.  
Photos: A.J. Stewart. 
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3.4  Cosyntropin use in the ACTH stimulation test 
For projects I, II and V lyophilized cosyntropin (synthetic ACTH; Cortrosyn, 
Amphastar Pharmaceuticals Inc, Rancho Cucamonga, Calif), was diluted with 
1.0 mL of sterile saline solution in accordance with the manufacturer’s 
instructions. Cosyntropin was then further diluted with sterile saline solution to 
a final concentration of either 10 µg/mL (for administration of the 0.25 and 0.5 
µg/kg doses) or 1 µg/mL (for administration of the 0.02 and 0.1 µg/kg doses). 
Unused reconstituted cosyntropin solution (1 µg/mL) was refrigerated in the 
original plastic saline solution bag for use within the next week. Diluted 
cosyntropin solution has been shown to remain fully stable (in concentrations as 
low as 0.5 µg/mL) for at least 4 months when refrigerated in plastic containers.40 
3.5 Radioimmunoassays 
Cortisol, ACTH and insulin concentrations were measured in duplicate using 
radioimmunoassays designed for analysis of human hormones (Figure 5).  The 
Coat-A-Count cortisol direct radioimmunoassay (In-vitro Diagnostic Test Kit, 
Diagnostic Products Corporation, Los Angeles, CA) had been previously 
validated in horses and was used in all studies I, II, IV and V (Funk et al., 2011; 
Golland et al., 1999). The inter-assay and intra-assay coefficients of variation 
ranged from 7.1% to 7.7% and from 6.1% to 8.1%, respectively for cortisol. The 
laboratory reference interval for cortisol concentration in normal horses was 1.49 
– 6.45 µg/dL (Schreiber et al., 2012).    
    In projects I and II plasma endogenous ACTH concentration was measured 
by use of a sandwich immunoradiometric assay previously validated for use in 
horses (Adrenocorticotropic hormone immunoradiometric assay, Nichols 
Institute, San Clemente, Calif.) (Marc et al., 2000; Golland et al., 1999). The 
inter-assay and intra-assay coefficients of variation were, for values < 30 
pg/mL, 9.2% and 4.5%, respectively (Marc et al., 2000). For projects IV and V 
the ACTH immunoradiometric assay from Scantibodies Laboratory Inc, 
Santee, CA had intra- and inter-assay coefficients of variation of  < 15% and < 
19%, respectively (Schreiber et al., 2012; Funk et al., 2011). The upper limit of 
the laboratory reference interval was 28 pg/mL for the summer period 
(Schreiber et al., 2012; Funk et al., 2011). 
    Equine serum insulin was measured using a radioimmunoassay previously 
validated in horses. The Coat-A–Count cortisol direct radioimmunoassay, 
(Diagnostic Products Corp, Los Angeles, CA) intra- and inter-assay variation: 
5.2% and 6.4% respectively) as previously described (Reimers et al., 1982),(de 






3.6 Definition of SIRS and SIRS Score 
The diagnosis of SIRS was based on the presence of 2 or more of the following 
criteria: hyperthermia (>38.6°C) or hypothermia (<36.1°C), tachypnoea (> 24 
breaths/minute), tachycardia (> 45 beats/minute), > 10% band neutrophils, 
leukopenia (white cell count < 6,000/μL) or leucocytosis (white cell count > 
12,000/μL).(Arroyo et al., 2017) SIRS scores were defined by the number of 
SIRS criteria. Horses with any two SIRS criteria were allocated to group 2; any 
three SIRS criteria in group 3, etc. For example, a horse presenting with pyrexia 
and leukopenia would be in group 2, while a horse with pyrexia, tachypnoea, 
tachycardia and leucocytosis would be in group 4 (Bertin et al., 2018a). 
 
 
Figure 5 Morris Animal Foundation Veterinary Summer Scholarship students assiting 
with sample preparation for measuring hormone concnetrations using 
radioimmunoassays. All students under went laboratory radiation safety training 
Photos: A.J. Stewart. 
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3.7 Clinicopathological data collected (III-V) 
For projects III –V the data recorded included signalment, physical examination 
findings and routine bloodwork at admission (haematological and biochemical 
data). Signalment data included gender, age and breed. Presenting physical 
examination findings recorded included rectal temperature (°C), heart rate 
(beats/minute), respiratory rate (breaths/minute), mucous membrane colour 
(grades 0-3), estimated percent dehydration (%), capillary refill time (seconds) 
and rectal examination findings. Presenting haematological data recorded 
included white blood cell count (1000 cells/µL), neutrophil count (1000 cells/ 
µL), lymphocyte count (1000 cells/µL), band neutrophil count (1000 cells/µL), 
packed cell volume (%). Presenting biochemical data recorded included total 
protein (g/dL), albumin (g/dL), creatinine (mg/dL), blood urea nitrogen (mg/dL, 
lactate, fibrinogen (mg/dL), sodium (mEq/L), chloride (mEq/L), potassium 
(mEq/L), bicarbonate (mEq/L), glucose (mg/dL), venous base excess (mEq/L), 
total calcium (mg/dL), ionized calcium (mmol/L), total magnesium (mg/dL), 
ionized magnesium (mmol/L). Abdominocentesis data recorded included total 
protein (g/dL), specific gravity, white cell count (1000 cells/ µL) and cytological 
description.  
    The mean heart rate (beats/minute) and daily total volume of reflux on each 
day of hospitalisation (litres) was also recorded. Surgical or necropsy findings 
(where appropriate), length of hospitalisation and total bill ($USD) were 
tabulated. A severity of illness score (1 to 3) and pain score (1-3) was recorded 
for admission and overall based on clinical judgement.  
3.8 Statistical analysis  
3.8.1 Project I 
The results were presented as mean ± SD. For each time point in each horse, 
delta cortisol concentration was calculated as cortisol concentration measured at 
that time minus the baseline cortisol concentration. Differences in endogenous 
cortisol and ACTH concentrations, ACTH-stimulated cortisol concentrations, 
delta cortisol concentrations, and CBC results over time were analysed by means 
of repeated-measures ANOVA followed by the least significant difference test. 
Analyses were performed with standard software. (SAS software, version 9.1, 
SAS Institute Inc, Cary, NC.)  The dose effect at each time point was determined 
by comparison of the ACTH-stimulated cortisol concentration with the cortisol 
concentration measured after administration of saline solution. The cortisol 
concentration measured at each time point, for each cosyntropin dose, was 
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compared with the baseline cortisol concentration. Baseline endogenous serum 
cortisol and plasma ACTH concentrations were also compared among days that 
samples were collected. Differences in maximum cortisol concentration and 
time of maximum cortisol concentration between doses were determined by 
using the Friedman repeated-measures test, with post hoc comparisons 
performed using the Student-Newman-Keuls method (SigmaStat for Windows, 
version 1.0, Jandel Scientific, SPSS Inc, Chicago, Ill.) For all analyses, values 
of P < 0.05 were considered significant. 
3.8.2 Project II 
Results are summarized as mean ± SD values. For each time point after 
baseline for each foal, delta cortisol concentration was calculated as cortisol 
concentration measured at that time minus the baseline cortisol concentration. 
Differences in ACTH-stimulated cortisol concentrations, delta cortisol 
concentrations, and CBC results were analyzed via the mixed model for 2-D 
(time and dose) repeated-measures ANOVA and the Scheffe test for multiple 
comparisons. Analyses were performed with standard software (SAS software, 
version 9.1, SAS Institute Inc, Cary, NC.). The dose effect at each time point 
was determined by comparing the ACTH-stimulated cortisol concentration 
with the cortisol concentration measured after administration of saline solution. 
For each cosyntropin dose, cortisol concentration measured at each time point 
was compared with the baseline concentration. Baseline endogenous serum 
cortisol and plasma ACTH concentrations were also compared among days 
that samples were collected. Differences in maximum cortisol concentration 
and time of maximum cortisol concentration between doses were determined. 
For all analyses, values of P < 0.05 were considered significant. 
3.8.3 Project III 
Horses were categorized based on survival, hyperinsulinemia, hyperglycaemia 
and number of SIRS criteria and compared with P < 0.05 considered statistically 
significant. Normality was assessed by a Shapiro-Wilk normality test. Data 
following normal distribution were reported as mean ± SD and compared with 
an unpaired t-test, whereas data not following a normal distribution were 
reported as median [range] and compared using a Mann-Whitney U-test. A 
receiver operating characteristic (ROC) curve was plotted to analyse the 
prognostic value of a given variable (serum insulin, serum glucose or ratios). 
When more than 2 groups were compared, an ANOVA was used for normally 
distributed data and a Kruskal-Wallis test was used for non-normally distributed 
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data with a Dunn’s post hoc test when appropriate. Categorical data were 
reported as counts and percentage of horses in which the variable was 
documented and compared using either a Chi-square test or a Fisher’s exact test 
depending on expected counts. Odds ratios and 95% confidence intervals were 
calculated when appropriate. Statistical analysis was performed using 
commercially available statistical software (Prism, GraphPad Software, Inc. La 
Jolla, CA 92037, USA). 
3.8.4  Project IV 
Horses were categorized based on survival (discharged alive or not), presence of 
SIRS (≥ 2 SIRS criteria), number of SIRS criteria (SIRS score) and presence of 
an ischemic gastrointestinal lesion and compared, with P < .05 considered 
statistically significant. Normality was assessed by a Shapiro-Wilk normality 
test. A receiver operating characteristic (ROC) curve was plotted to analyse the 
prognostic value of a given variable (ACTH, cortisol or ACTH/cortisol ratio) at 
admission for predicting survival, presence of an ischemic lesion or SIRS. A 
two-way repeated measures ANOVA was used to determine the effect of 
survival, SIRS or ischemia and time and Sidak’s multiple comparisons test was 
used for post hoc analysis. Data following a normal distribution were reported 
as mean ± SD values and data not following a normal distribution were reported 
as median [range]. Categorical data were reported as counts and percentage of 
horses in which the variable was documented and compared using either a Chi-
square test or a Fisher’s exact test depending on expected counts. Odds ratios 
(OR) and 95% confidence intervals were calculated when appropriate. Any 
groups with low numbers of data were excluded from statistical analysis. 
Commercially available statistical software was used (Prism, GraphPad 
Software, Inc. La Jolla, CA 92037, USA). 
3.8.5  Project IV 
The statistical analysis was identical to project IV except for the following: For 
admission data, data following normal distribution were compared with an 
unpaired t-test or a one-way ANOVA, depending on the number of groups 
compared, whereas data not following a normal distribution were compared 
using a Mann-Whitney U-test or a Kruskal-Wallis test, depending on the number 
of groups compared. To compare data during hospitalisation, a two-way 
repeated measures ANOVA was used to determine the effect of outcome of 
interest (survival, SIRS and ischemia) and time using data from horses that had 






This section summarizes the main results from the separate studies. More 
detailed descriptions are presented in each of the papers (I –V). Figures and 
tables referred to the respective published papers and manuscripts are located at 
the end of the thesis 
4.1 Project 1: Validation of a low-dose ACTH stimulation 
test in healthy adult horses 
4.1.1 Baseline cortisol and ACTH concentrations 
Baseline endogenous plasma ACTH concentrations in the 40 samples obtained 
prior to the 5 tests performed in the 8 horses ranged from (mean ± SD, and from 
6 to 37 pg/mL (19.2 ± 5.6 pg/mL). Baseline endogenous serum cortisol 
concentrations ranged from 76 to 264 nmol/L (mean ± SD, 172.4 ± 44.8 nmol/L) 
[2.7 to 9.6 µg/dL (6.2 ± 1.62 µg/dL)]. Mean baseline serum cortisol and plasma 
ACTH concentrations did not differ between test days. No significant increases 
in serum cortisol concentration were detected after administration of saline 
solution; however, there was a significant decrease in serum cortisol 
concentration 240 minutes after administration of saline solution, compared with 








Figure 6. Mean serum cortisol concentration in 8 healthy adult horses given saline (0.9% 
NaCl) solution or 1 of 4 doses (0.02, 0.1, 0.25, and 0.5 µg/kg [0.009, 0.045, 0.114, and 
0.227 µg/lb]) of cosyntropin. +Significantly (P ≤ 0.05) different from concentration 
measured at the same time point after administration of saline solution. *Significantly (P ≤ 
0.05) different from baseline (time 0) concentration for that dose. 
4.1.2 Cortisol concentrations after ACTH stimulation 
For all 4 doses of cosyntropin, serum cortisol concentrations were significantly 
increased, compared with baseline concentrations at T = 30 and 60 minutes after 
cosyntropin administration, and significantly increased compared with 
concentration at T = 30 minutes after administration of saline solution. After a 
cosyntropin at a dose of 0.02 and 0.1 µg/kg, cortisol peaked at T = 30 and was 
1.5 and 1.9 times the baseline concentration (Table 1 of paper I). After a 
cosyntropin dose of 0.25 and 0.5 µg/kg, cortisol peaked at 90 minutes and was 
2 and 2.3 times baseline.  
    A maximum adrenal response was obtained between 30 and 90 minutes after 
administration of cosyntropin at a dose of 0.1 µg/kg, between 30 and 120 
minutes after administration of cosyntropin at a dose of 0.25 µg/kg, and 























































4.1.3 Delta cortisol concentrations after ACTH stimulation 
No significant differences were detected among delta cortisol concentrations at 
T = 30 at a dose of 0.02 µg/kg and delta cortisol concentrations at T = 30 and 
60 minutes at a dose of 0.1 µg/kg (Table 2 of paper I). Delta cortisol peaked at 
T = 90 minutes at a dose of 0.25 or 0.5 µg/kg, and for both doses, peak delta 
cortisol concentration was significantly higher than obtained after the 2 lower 
doses. 
4.1.4 Haematological changes after ACTH stimulation 
Significant increases in WBC count, neutrophil count, and the 
neutrophil/lymphocyte ratio and decreases in eosinophil count were detected 
(Table 3 of Paper I). Timing and magnitude of the changes were dependent on 
the cosyntropin dose. There was a doubling of the neutrophil/lymphocyte ratio; 
compared with the baseline ratio at T = 240 minutes after administration of the 
0.25 or 0.5 µg/kg doses, although this was only significant at the higher dose. 
For all 4 doses of cosyntropin, there were no significant differences in 
lymphocyte count, monocyte count, heamatocrit, or RBC count over time. 
4.2 Project II: Validation of a low-dose ACTH stimulation 
test in healthy neonatal foals 
4.2.1 Baseline cortisol and ACTH concentrations 
Baseline endogenous plasma ACTH concentrations in the 55 samples obtained 
prior to the 5 tests performed in the 11 foals ranged from 7 to 33 pg/mL (16.6 ± 
6.3 pg/mL). Baseline endogenous serum cortisol concentrations ranged from 14 
to 149 nmol/L (mean ± SD, 52.7 ± 27.3 nmol/L) [0.51 to 5.4 µg/dL (1.9  ± 0.99 
µg/dL) Mean baseline serum cortisol and plasma ACTH concentrations did not 
differ among test days. 
 
4.2.2 Cortisol concentrations after ACTH stimulation 
A significant increase in cortisol concentration was not detected after 
administration of 0.02 µg/kg of cosyntropin; however, significance was 
approached when comparing T = 0 to T = 20 (P = 0.061) and 30 minutes (P = 
0.067; Figure 7). After the 0.1 and 0.25 µg/kg doses of cosyntropin, cortisol was 
significantly (P = 0.02 to < 0.001) increased, compared with baseline 
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concentrations at T = 10, 20 and 30 minutes. For the 0.5 µg/kg dose, serum 
cortisol concentration was significantly (P = 0.002 to < 0.001) increased, 
compared with baseline concentrations between 10 and 60 minutes. 
Cortisol peaked at T = 20 minutes after administration of doses of 0.02, 0.1, 
and 0.25 µg/kg, with peak concentrations 1.7, 2.0, and 1.9 times baseline 
concentrations, respectively. Cortisol peaked at T = 30 minutes after the 0.5 
µg/kg dose, with peak concentration 2.2 times baseline. No significant 
differences were detected in peak cortisol concentrations after the 0.25 µg/kg 
dose at 20 and 30 minutes and the 0.5 µg/kg dose at 30 minutes. After the 0.25 
and 0.5 µg/kg doses, no significant differences were detected among serum 
cortisol concentrations at 10, 20, 30, and 60 minutes. 
 
Figure 7. Mean serum cortisol concentrations in 11 healthy neonatal foals administered 
saline (0.9% NaCl) solution or 1 of 4 doses (0.02, 0.1, 0.25, and 0.5 µg/kg [0.009, 0.045, 
0.114, and 0.227 µg/lb]) of cosyntropin. +Significantly (P ≤ 0.05) different from 
concentration measured at the same time point after administration of saline solution. 
*Significantly (P ≤ 0.05) different from baseline (time 0) concentration for that dose. 
4.2.3 Comparison of cortisol response between cosyntropin doses and 
saline solution  
After administration of saline, no significant differences were detected between 
cortisol concentrations at any time point or between cortisol concentrations after 














































to saline solution administration at T = 10 and 20 minutes. There was a 
significant (P < 0.001) difference among cortisol concentrations after 
administration of saline solution compared to cortisol after the 0.25 and 0.5 
µg/kg doses at T  = 30 minutes and after the 0.5 µg/kg dose at T = 60 minutes 
(P < 0.001). 
4.2.4 Delta cortisol response to various doses of cosyntropin  
After the administration of the saline solution there were no significant 
differences between any of the delta cortisol concentrations (Figure 8). Delta 
cortisol concentrations at T = 10, 20, and 30 minutes were significantly different 
after administration of the 0.1, 0.25, and 0.5 µg/kg doses of cosyntropin and at 
T = 60 minutes after the administration of the 0.5 µg/kg dose compared with 
administration of saline. Delta cortisol peaked at T = 20 minutes after the 0.1 
µg/kg dose, which was not different from the delta cortisol concentrations at T 
= 10 and 30 minutes. The peak delta cortisol concentration after administration 
of 0.25 µg/kg occurred at 30 minutes but was not different from the delta cortisol 
concentrations at 10 and 20 minutes. Delta cortisol concentration peaked at T = 
30 minutes after the 0.5 µg/kg dose, and was not different from the delta cortisol 
concentrations at 10, 20, and 60 minutes. 
 
Figure 8.  Mean delta cortisol concentrations in 11 healthy neonatal foals administered 
saline (0.9% NaCl) solution or 1 of 4 doses (0.02, 0.1, 0.25, and 0.5 µg/kg [0.009, 0.045, 
0.114, and 0.227 µg/lb]) of cosyntropin. +Significantly (P ≤ 0.05) different from 







































4.2.5 Effect of cosyntropin on haematological variables  
The neutrophil/lymphocyte (N/L) ratio increased 2.4-fold, from 4.76 ± 1.71 at 
baseline to 11.6 ± 11.6 at T = 120 minutes (P = 0.01). The lymphocyte count 
decreased from 1,555 ± 498 cells/µL at baseline to 1,122 ± 600 cells/µL at T = 
120 minutes (P = 0.04) after the 0.25 µg/kg dose. For all 4 doses of cosyntropin, 
no significant differences in neutrophil count, monocyte count, eosinophil count, 
haematocrit or RBC count over time were detected. There were no changes in 
any parameters after administration of saline. 
4.3 Comparison of Project I to Project II 
4.3.1 Comparison of cortisol response to administered doses of 
cosyntropin between foals and adult horses  
Adult horses had slightly higher baseline ACTH concentrations and much higher 
baseline cortisol concentrations (Figure 9a) than neonatal foals (Figure 9b). The 
cortisol response to 4 identical doses of cosyntropin administered to the 11 foals 
compared to that of 8 adult horses (Figure 2 of paper II) demonstrated that the 
ACTH-stimulated cortisol concentrations peaked later, were of higher 
magnitude, and were of a longer duration in adult horses, compared with foals. 
 
 
Figure 9a. Individual cortisol concentrations from one adult horses administered saline 

































Figure 9b. Individual cortisol concentrations from one neonatal foal administered saline 
(0.9% NaCl) solution and each of four doses (0.02, 0.1, 0.25, and 0.5 µg/kg) of cosyntropin. 
Note the lower endogenous and post cosyntropin cortisol concentrations compared to the 
adult horse.   
 
Figure 10. Mean serum cortisol concentrations in 11 healthy neonatal foals and 8 adult 
horses (mean  ±  SD age, 7.4 ±  3.5 years; range, 2 to 12 years) administered saline (0.9% 
NaCl) solution or 1 of 4 doses (0.02, 0.1, 0.25, and 0.5 µg/kg) of cosyntropin. Note the 
lower endogenous and post cosyntropin cortisol concentrations in the foals compared to the 
































4.4 Project III: Insulin dysregulation in horses with 
systemic inflammatory response syndrome 
4.4.1 Clinical data    
Fifty-eight horses met the inclusion criteria of SIRS, ranging from 5 to 32 years 
of age. The gastrointestinal system was affected in 53 horses (91%), respiratory 
system in 3 (5%) and the neurologic and reproductive systems in 1 case each 
(2% each). Fifteen horses had an explorative laparotomy and, based on surgery 
or necropsy reports, 15 (28%) had an ischemic lesion. 
Thirty-one horses (53%) had a SIRS score of 2, 18 horses (31%) of 3 and 9 
horses (16%) of 4. There were 36 survivors (62%). A necropsy was performed 
in 16 non-survivors (73%). 
4.4.2 Insulin  
At admission, hyperinsulinemia (> 20 µIU/mL) was diagnosed in 21 horses 
(36%) and was not associated with survival (P = 0.21); however, serum insulin 
 
 




was significantly lower in non-survivors (6.69 µIU/mL [0.06 – 24.34]) than 
survivors (12.6 µIU/mL [0.76 – 55.16]; P = 0.04, Figure 11).  
Hyperinsulinemia at any time during hospitalisation (Day 0, 2, 4 or 6) was 
associated with survival (P = 0.02, Table 1 of paper III) with hyperinsulinemic 
horses 4 times more likely to survive. Severe hyperinsulinemia (insulin > 50 
µIU/mL) was present in 6 horses but was not associated with survival (P = 0.39). 
Hyperinsulinemia or serum insulin concentration at any time during 
hospitalisation were not associated with SIRS group (P = 0.56 and P = 0.90 
respectively). 
The ROC curve showed that a serum insulin concentration > 8.82 µIU/mL 
(suggested optimal cut-off by the algorithm) was a poor diagnostic test to predict 
survival with an area under the ROC of 0.67 yielding to a sensitivity of 60.0% 
[36.1 – 80.9] and a specificity of 76.5% [58.8 – 89.3]. 
4.4.3 Glucose  
At admission, hyperglycaemia (> 124 mg/dL) was diagnosed in 44 horses (88%) 
and was associated with non-survival (P = 0.03, Table 1 of paper III) with 
hyperglycaemic horses 5 times less likely to survive. At admission serum 
glucose was significantly higher in non-survivors (165 mg/dL [90 – 387] versus 
survivors 137 mg/dL [45 – 329], p = 0.04, Figure 12).  
 
 
Figure 12. Figure 2: Serum glucose (mg/dL) at admission in survivors and 




Presence of hyperglycaemia and serum glucose were both associated with SIRS 
group (P < 0.01) Figure 13). 
Using a calculated optimal cut-off value of 150 mg/dL, the ROC curve 
showed that glucose was a poor predictor of survival with an area under the ROC 
curve of 0.66 resulting in a sensitivity of 71.4% [47.8 – 88.7] and a specificity 
of 63.9% [46.2 – 79.2]. 
 
4.4.4 Ratio correlations     
Insulin/glucose ratio, reflecting insulin secretion, was significantly lower in non-
survivors (0.033 [< 0.01 – 0.22]) than survivors (0.1 [< 0.01 – 0.41]; P < 0.01, 
Figure 14). The ROC curve showed that an insulin/glucose value > 0.06 was a 
fair predictor of survival with an area under the ROC of 0.75 resulting in a 
sensitivity of 76.2% [52.8 – 91.8] and a specificity of 74.3% [56.7 – 87.5]. 
Glucose/insulin ratio, reflecting insulin sensitivity, was significantly higher 
in non-survivors (28.5 [1.8 – 709.1]) than survivors (10 [2 – 62.4]; P < 0.01, 
Figure15). A glucose/insulin ratio below 10, indicative of peripheral tissue 
insulin resistance, was obtained in 22 horses (38%) but was not associated with 
survival (P = 0.06) (Frank, 2011). A glucose/insulin ratio below 4.5, indicative 
of severe peripheral tissue insulin resistance, was obtained in 8 horses (14%) but  
 
 
Figure 13. Serum glucose (mg/dL) at admission in horses with a SIRS score of 2, 3 and 4 






Figure 14. Insulin/glucose ratio, reflecting insulin secretion, in survivors and non-survivors 
(* P < 0.05). 
 
 
Figure 15. Glucose/insulin ratio, reflecting insulin sensitivity, in survivors and non-





was not associated with survival (p = 0.11).35 Using an optimal cut-off value of 
12.5, the ROC curve showed that the glucose/insulin ratio was a fair diagnostic 
test to predict survival with an area under the ROC curve of 0.73 yielding a 
sensitivity of 71.4% [47.8 – 88.7] and specificity of 68.6% [50.7 – 83.2]. 
At admission, overall, there was no correlation between serum insulin and 
glucose (P = 0.13); however, in survivors, there was a significant correlation 




Figure 16. Correlation between serum insulin and glucose in survivors (p = 0.002, R2 = 0.2468) 




4.5 Project IV: Cortisol and ACTH concentrations in 
horses with systemic inflammatory response 
syndrome. 
4.5.1 Clinical and outcome data 
 
There were 151 horses ranging from 1 to 34 years of age (median of 11 years).  
Body systems affected were the gastrointestinal system in 144 horses (96.6%), 
the respiratory system in 3 horses (2%), and the neurologic and reproductive 
systems in 1 case each (0.7% each). An exploratory laparotomy was performed 
in 45 horses and, based on surgery (27 horses) or necropsy reports (23 horses), 
50 horses had an ischemic lesion. There were 106 survivors. Of the 45 non-
survivors, 30 cases were euthanized during the first evening, 4 of which had 
ruptured bowel at admission and 4 additional cases were euthanized during 
exploratory laparotomy. Of the 45 non-survivors, 2 horses were classed as SIRS 
score 0, 12 as score 1, 13 as score 2, 11 as score 3, and 7 as score 4; therefore 31 
non-survivors (69%) met the criteria for SIRS.  Of the 106 survivors, 17 horses 
were classed as SIRS score 0, 32 as score 1, 38 as score 2, 15 as score 3, 4 as 
score 4 and 1 horse as score 5; therefore, 58 horses (55%) met the criteria for 
SIRS. In non-survivors (n = 45) the median SIRS score: 2 [0 – 4] was higher 
than in survivors (n = 106): 2 [0 – 5]; P = .0041. Of the 50 horses with ischemic 
lesions, 18 survived and 32 did not survive (Figure 17). 
 










   Ischemic lesions 
 
Figure 17. 106 survivors: 17 with SIRS and 18 with ischemic lesions 
45 non-survivors: 31 with SIRS, 32 with ischemic lesions 
 
Survivors         Non-survivors 
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4.5.2 Survival  
    ACTH 
At admission, plasma ACTH was significantly lower in survivors (15.7 pg/mL 
[0.9 – 775.1]; n = 103) than non-survivors (56.7 pg/mL [5.8 – 563.8]; n = 45); P 
<.0001. In survivors, ACTH significantly decreased over time, P < 0.05 (Figure 
18 and supplementary table 1 of paper IV). Of the surviving horses, (71/83, 
85.6%) had an ACTH concentration within the reference interval at admission, 
whereas 49.2% of horses (32/65) with ACTH outside the reference interval 
survived. The number of horses with ACTH concentrations below reference 
interval for each day of hospitalisation is shown in Table 1 of paper IV. Of the 
surviving horses, (95/103) 92% had a normal ACTH concentration prior to 
discharge. When ACTH concentration was beyond the reference interval at 
admission, the OR for non-survival was 6.10 [2.73– 13.68], P < 0.0001. The 
ROC curve showed that an ACTH concentration  > 30.5 pg/mL (the algorithm’s 
suggested optimal cut-off) was a fair predictor of survival with an area under the 
ROC of 0.75, sensitivity of 71.1% [55.7 – 83.6] and specificity of 71.8% [62.1 
– 80.3]. On day 2, 91.2% of horses (62/68) with ACTH within reference interval 
survived, whilst 68.6% of horses (11/16) with ACTH outside reference interval 
survived. For ACTH concentration outside the reference interval on day 2, the 
OR for non-survival was 4.70 [1.26 – 15.54], P = .016. 
 
    Cortisol 
At admission, serum cortisol was significantly lower in survivors 9.7 µg/dL [1.5 
– 38.6]; n = 104) than non-survivors (15.8 µg/dL [3.2 – 55.9]; n = 45): P =.0003. 
Overall cortisol decreased over time, P < 0.05 (Figure 18b). The ROC curve 
showed that cortisol > 11.7 µg/dL  as a poor predictor of survival with an area 
under the ROC of 0.68, sensitivity of 68.9% [53.4 – 81.8], specificity of 67.3% 











Figure 18a-b. Plasma ACTH (1a), serum cortisol (1b) at admission, day 2, day 4 and day 6 
of hospitalization in survivors (black) verses non-survivors (grey).  
 
* difference between survivors and non-survivors at admission for ACTH (P < .0001), and 
cortisol (P = .0003).  The reference range is marked by a dotted horizontal line.  
† higher than upper limit of reference range for ACTH of 28.0 pg/mL (P = .0001), A 
different letter indicates a significant difference between days (P < .05). 
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    ACTH/cortisol ratio 
At admission, the ACTH/cortisol ratio was significantly higher in non-survivors 
(3.8 [0.8 – 32.6]; n = 45) than survivors (1.8 [0.1 – 66.6]; n = 101), P = 0.0001 
(Figure 18c), but no changes were detected over time in survivors or non-
survivors. The ROC curve showed that an ACTH/cortisol ratio concentration > 
2.6 was a poor diagnostic test to predict survival with an area under the ROC of 
0.696, with sensitivity of 64.4 [48.8 – 78.1], specificity of 67.3% 67.3 [57.3 – 
76.3] and a likelihood ratio of 1.97 for non-survival.  
 
4.5.3 SIRS score 
    ACTH 
At admission, horses with SIRS had higher ACTH concentrations at admission 
compared with days 4 and 6 (P < .05), but there was no difference was detected 
between horses with and without SIRS (P = .19) (Figure 19a and supplementary 
table 2 of paper IV) No statistically significant difference in ACTH 
concentrations were detected between any individual SIRS score groups (P = 





Figure 18c. ACTH/cortisol ratio at admission, day 2, day 4 and day 6 of hospitalization in 
survivors (black) verses non-survivors (grey).  
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Figure 19a-b. Plasma ACTH (19a) and serum cortisol (19b) at admission, day 2, day 4 and 
day 6 of hospitalization for horses with SIRS (grey) verses without SIRS (black).  
The reference range is marked by a dotted horizontal line.  
 
† higher than upper limit of reference range for cortisol 6.5 µg/dL (P < .05). A different letter 
indicates a significant difference between days (P < .05) 
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However, the ACTH concentration was higher than the reference range at 
admission and higher than day 4 for horses with a SIRS scores cores of 4 and 5 
(P < .05) (supplementary Figure 1a and supplementary table 3 of paper IV) 
 
    Cortisol 
At admission, horses with SIRS had higher cortisol concentrations at admission 
compared with days 2, 4 and 6 (P < .05), while horses without SIRS had higher 
cortisol at admission compared with days 2 and 4 (P < .05). At admission Both 
SIRS and no SIRS groups of horses had cortisol concentrations higher than the 
reference range at admission (Figure 19b). The cortisol concentration was above 
reference range at admission in all SIRS groups (P < .05), and there were no 
differences between SIRS groups (P = 0.21) and no difference between horses 
with or without SIRS (P = .88) at admission.). The cortisol concentration was 
higher at admission compared to day 2 and 4 in the SIRS score 1, 2 and 3 groups 
(P < .05) (supplementary Figure 1b of paper IV). 
 
    ACTH/cortisol ratio 
Horses with SIRS had higher ACTH/cortisol ratio at admission compared to 
horses without SIRS (P = .042). (Figure 19c) There were no differences detected 
in the ACTH/cortisol ratio between SIRS score groups (P = 0.21 at admission) 
or over time. (supplementary Figure 1c of paper IV) 
 
 
Figure 19c. ACTH/cortisol ratio at admission, day 2, day 4 and day 6 of hospitalization 
for horses with SIRS (grey) verses without SIRS (black).  
* difference between non-SIRS and SIRS at admission for ACTH/cortisol ratio 
 (P = .04). 
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4.5.4 Ischemic gastrointestinal lesion 
Of the 50 horses with ischaemic lesions only 18 (36%) survived, while 87.1% 
(88/101) (87.1%) with non-ischaemic lesions survived. Horses with an ischemic 
lesion were 12 times more likely to not to survive, (OR: 12.03 [5.36 – 25.54], P 
< 0.0001). Although not statistically significant, there was a trend for the SIRS 
score in horses with ischemic lesions (n = 51: 2 [0 – 5]) to be higher than those 
with non-ischemic lesions (n = 100: 2 [0 – 4]: P = 0.076).  
 
    ACTH  
At admission horses with ischemic gastrointestinal lesions had higher plasma 
ACTH concentrations than those without ischemic lesions at admission (P < 
.0001). Horses at admission horses with ischemic lesions had ACTH 
concentrations greater than the reference range at admission interval (P < .05), 
and these declined by days 2, 4 and 6 (P < .05). There was no change over time 
for horses with non-ischemic lesions. (Figure 20a and supplementary table 4 of 
paper IV). The ROC curve showed that an ACTH concentration > 28.5 pg/mL 
was a poor diagnostic test to predict ischemia with an area under the ROC of 
0.73, with sensitivity of 66.7% [52.1 – 79.2], specificity of 69.1% [58.9 – 78.1] 
and a likelihood ratio of 2.16 for presence of an ischemic gastrointestinal lesion. 
 
    Cortisol  
At admission, horses with ischemic lesions had higher cortisol concentrations 
than those without ischemic lesions at admission (P < .0001). Horses with and 
without ischemic lesions had higher cortisol concentrations at admission which 
declined throughout hospitalisation over time (P < .05). Cortisol was higher than 
the reference range at admission and on day 2 for those horses with ischemic 
lesions and at admission for those with non-ischemic lesions (P < .05) (Figure 
20b) of paper IV). The ROC curve showed that a cortisol concentration > 11.6 
µg/dL was a poor predictor of ischemia with an area under the ROC of 0.73, 
with sensitivity of 70.6% [56.2 – 82.5], specificity of 69.4% [59.3 – 78.3] and a 
likelihood ratio of 2.31) for presence of an ischemic gastrointestinal lesion. 
 
    ACTH/cortisol ratio 
At admission horses with ischemic lesions had higher ACTH/cortisol ratio than 
those without ischemic lesions at admission (P = .0069), but there was no change 
in either group over time. (Figure 20c of paper IV). The ROC curve showed that 
an ACTH/cortisol ratio > 2.4 was a poor predictor ischemia with an area under 
the ROC of 0.63, with sensitivity of 62.8% [48.1 – 75.9], specificity of 64.2% 









Figure 20a-b. Plasma ACTH (20a) and serum cortisol (20b) at admission, day 2, day 4 and 
day 6 of hospitalization in horses with ischemic gastrointestinal lesions (grey) verses horses 
without ischemic lesions (black).  
 
* difference between ischemic and non-ischemic at admission for ACTH (P < .0001) and 
cortisol (P < .0001).  
The reference range is marked by a dotted horizontal line.  
† higher than upper limit of reference range for ACTH of 28.0 pg/mL and cortisol: 6.5 µg/dL 




4.6 Correlations between endocrine parameters in sick 
horses 
4.6.1 ACTH, Cortisol, insulin and glucose correlations in horses  
Overall, glucose and insulin (Figure 16), glucose and ACTH, and ACTH and 
cortisol were positively correlated (n = 126, P = 0.027, n = 141, P = 0.051 and 
n= 141, P = 0.02, respectively). In horses with SIRS, only cortisol and glucose 
were positively correlated (n = 68, P = 0.003 Figure 21a). In horses without 
SIRS, only glucose and insulin were positively correlated (n = 63, P = 0.005, 
Figure 21b). In survivors, glucose and insulin were positively correlated (n = 87, 
P = 0.0008, Figure 21c), with a trend towards a positive correlation between 
glucose and ACTH (n =102, p = 0.058). In non-survivors, no correlations were 









Figure 20c. ACTH/cortisol ratio at admission, day 2, day 4 and day 6 of 
hospitalization in horses with ischemic gastrointestinal lesions (grey) verses horses 
without ischemic lesions (black).  







Figure 21a. In horses with SIRS, only cortisol and glucose were positively correlated  





Figure 21b In horses without SIRS, only glucose and insulin were positively correlated  






Figure 21c In survivors, only glucose and insulin were positively correlated  




4.7 Project V: Identification of Adrenal Dysfunction in 
Critically Ill Adult Horses. 
4.7.1 Clinical and outcome data 
There were 58 horses were included, ranging in age from 1 to 24 years of age 
(median of 10 years).  There were 57 horses (98%) with a final diagnosis 
involving the gastrointestinal system. There were 29 medical cases: 7 with colitis 
[3 Aeromonas spp (1 with haemoabdomen and a large colon impaction), 2 
Salmonella spp, 2 of undetermined aetiology]; 6 ileal impactions, 5 undiagnosed 
medical colics, 3 impactions of the small colon, 2 impactions of the large colon, 
2 left dorsal displacements and 1 each of anterior enteritis, rectal mass, sand 
colic, oesophageal squamous cell carcinoma and. There were 23 surgically 
managed cases: 8 right dorsal displacements (1 ruptured at surgery and one 
euthanized on day 3 due to mesenteric melanomas observed at surgery), 4 
strangulating lipomas, 4 torsions of the large colon, 3 small intestinal 
entrapments in the epiploic foramen, 1 each of small colon impaction, idiopathic 
peritonitis, focal jejunal eosinophilic enteritis and incarcerated small intestine 
due to a Streptococcus equi subsp. equi abscess that was euthanized at surgery. 
Five cases were euthanized at presentation due to poor prognosis: 3 with 
strangulating small intestinal lesions and 1 case each of torsion of the large colon 
and severe gastritis. There were 14 cases with an ischemic gastrointestinal 
lesion. There was also 1 horse with severe pleuropneumonia. 
   There were 44 (76%) survivors. Among the 14 (24%) non-survivors, 5 cases 
were euthanized at admission, 2 during exploratory laparotomy and 1 case of 
Salmonella spp colitis and septicaemia was euthanized during the first evening. 
Two more cases were euthanized prior to day 4 and 1 prior to day 6 sampling. 
Of the non-survivors, ACTH and cortisol results were available at admission for 
14 cases, on day 2 for 6 cases, on day 4 for 4 cases and on day 6 for only 3 cases. 
For the survivors, ACTH and cortisol results were available at admission for 44 
cases, on day 2 for 40 cases, on day 4 for 31 cases and on day 6 for 19 cases. Of 
the 14 non-survivors, 5 horses were classified as SIRS score 1, 4 horses as score 
2, 3 horses as score 3, 2 horses as score 4; therefore 9 horses (64%) met the 
criteria for SIRS.  Of the 44 survivors, 6 horses were classified as SIRS score 0, 
10 horses as score 1, 19 horses as score 2, 9 horses as score 3, therefore 28 horses 
(64%) with SIRS. Overall, 37 horses (64%) met the criteria for SIRS.  
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4.7.2 Outcome of survival  
The median SIRS score in non-survivors (2 [1 – 4]; n = 14) was not significantly 
higher than in survivors: (2 [0 – 3]; n = 44; P = 0.30) Plasma ACTH was 
significantly higher in non-survivors (37.5 pg/mL [8.4 – 134.8]; n = 14) than 
survivors (16.5 pg/mL [2.0 – 775.1]; n = 44:P = 0.006) at admission and also on 
day 2, with non-survivors  higher (54.8 pg/mL [6.8 – 131.6]; n = 6) than  
survivors (13.6 pg/mL [0.5 – 278.0]; n = 40: P = 0.006). Overall, ACTH 
significantly decreased over time P = 0.009 when all horses were considered (n 
= 58). (Figure 22a) 
Serum cortisol at baseline was significantly higher in non-survivors (15.1 µg/dL 
[3.9 – 51.3]; n = 14) than survivors (9.4 µg/dL [3.9 – 38.6]; n = 44: P = 0.02) at 
admission. In all horses, cortisol decreased over time, P < 0.0001 (Figure 22b). 
After administration of cosyntropin, there was no difference in cortisol at T = 30 
between non-survivors and survivors (P = 0.14), or over time (P = 0.30). There 
was no difference in delta-cortisol between non-survivors and survivors (P = 





Figure 22a. Plasma ACTH at admission, day 2, day 4 and day 6 of hospitalization in  
survivors (black) verses non-survivors (grey).  
 
* difference between survivors and non-survivors at admission (P = 0.036) and day 2  









Figure 22b. Serum cortisol at admission, day 2, day 4 and day 6 of hospitalization in 
survivors (black) verses non-survivors (grey).  
 
* difference between survivors and non-survivors at admission (P = 0.021).  
 A different letter indicates a significant difference between days (P < .05) 
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For ACTH stimulation, there was no significant effect of stimulation (P = 0.17), 
however there was a difference between basal cortisol between survivors and 
non-survivors (P = 0.02), but not at T = 30 minutes (P = 0.64). (Figure 23)  
4.7.3 Outcome of SIRS score  
There was no difference in the ACTH, basal cortisol, or delta-cortisol 
concentrations at admission in horses with or without SIRS (P = 0.73, 0.27, 0.5), 
however the T =30 minutes cortisol concentration was lower in horses with SIRS 
(14.8 ± 4.4 µg/dL) verses versus those without SIRS (17.8 ± 5.0 µg/dL; P = 
0.002). Overall, ACTH, basal cortisol (Figure 24) and T = 30 cortisol but not 
delta-cortisol decreased over time (P = 0.01, < 0.0001, 0.06 and 0.96). There was 
a significant effect of ACTH stimulation (P = 0.05), and a difference between 
horses with and without SIRS (P = 0.025) due to an effect at T = 30 minutes (P 
= 0.05) but not basal cortisol (P = 0.32). There was an overall significant effect 
of ACTH stimulation (P = 0.05) and an effect of SIRS (P = 0.02), where at T = 




Figure 23.  Mean ± SD serum cortisol at baseline and 30 minutes after administration of 
0.1 µg/kg IV of cosyntropin at admission for survivors (black) verses non-survivors 
(grey).  
 
* difference basal cortisol between survivors and non-survivors (P = 0.018).  There was 
no difference at 30 minutes (P = 0.64). 
 78 
 
At admission, no statistically significant differences were detected in ACTH, 
basal cortisol or delta-cortisol concentrations between any individual SIRS score 
groups (P = 0.47, 0.22, 0.82), however, the T = 30 cortisol was lower between 
horses with SIRS score 2 (12.4 µg/dL [5.9 – 18.3]) than SIRS score 1 (18.1 
µg/dL [12.2 – 27.3]; P = 0.002).  There was an overall effect of ACTH 
stimulation (P = 0.03), and effect of SIRS score (P = 0.05).  
 
4.7.4 Outcome of ischemic gastrointestinal lesion  
Of the 19 horses with ischaemic lesions only 53% (10/19) survived, while 87% 
(34/39) with non-ischaemic lesions survived. At admission, basal cortisol 
concentrations were higher in horses with ischemic lesions (13.2 µg/dL [6.9 – 
51.3]) than those without ischemic lesions (9.4 µg/dL [3.9 – 38.6]; P = 0.04). 
There were no differences detected between horses with and without ischemic 
lesions at admission for ACTH, T =30 cortisol, or delta-cortisol (P = 0.18, 0.22, 
0.29). ACTH was higher in horses with non-ischemic lesions at admission verses 
day 2 (P = 0.04), day 4 (P = 0.04) and day 6 (0.04). (Figure 25a) In horses with 
ischemic lesions, the basal cortisol was higher at admission versus day 4 (P = 
0.003) and day 6 (P = 0.0007). For horses with non-ischemic lesions basal  
 
 
Figure 24. Serum cortisol at admission, day 2, day 4 and day 6 of hospitalization for 
horses with SIRS (grey) verses without SIRS (black).  
 









Figure 25a-b. Plasma ACTH (25a) and serum cortisol (25b) at admission, day 2, day 
4 and day 6 of hospitalization in horses with ischemic gastrointestinal lesions (grey) 
verses horses without ischemic lesions (black).  
 
* difference between ischemic and non-ischemic at admission for ACTH (P = 0.18) and 
cortisol (P = 0.036).  A different letter indicates a significant difference between days 
(P < .05).. 
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cortisol was higher at admission verses day 2 (P = 0.001), day 4 (P = 0.0003)  
and day 6 (P <0.0001). (Figure 25b). T = 30 cortisol was higher between 
admission and day 6 (P = 0.031) for horses with non-ischemic lesions.   
There was a significant effect of ACTH stimulation (P = 0.005) due to an 
increase in cortisol concentrations in horses without ischemic lesions (P = 
0.005), but no difference in horses with ischemic lesions (P = 0.97). There was 
also an effect of ischemia (P = 0.04), due to a higher basal cortisol concentration 
at in horses with ischemic lesions (P = 0.02) compared to horses without 
ischemic lesions, however there was no difference at T = 30 minutes (P = 0.59). 
(Figure 26) 
4.7.5 Adrenal dysfunction  
An inappropriately low basal cortisol less than the proposed cut-off of < 9.7 
µg/dL, was detected in 35/58 (55%) of horses at some time during 
hospitalisation; 26/58 (45%) at admission, 37/48 (77%) on day 2, 32/35 (91%) 
on day 4 and 22/22 (100%) on day 6. An inappropriately low basal cortisol than 
 
 
Figure 26. Mean ± SD serum cortisol at baseline and 30 minutes after administration of 
0.1 µg/kg IV of cosyntropin at admission, for horses with ischemic gastrointestinal 
lesions (grey) and those without ischemic lesions (black).  
 
* difference between basal cortisol in horses with ischemic and non-ischemic lesions   
(P = 0.018).  There was no difference at 30 minutes (P = 0.59). Different letters indicate a 
difference between basal cortisol concentrations and 30 minutes post cosyntropin in 
horses with non-ischemic lesions (P = 0.0047). There was no difference between basal 
and 30 minutes cortisol concentrations for horses with ischemic lesions (P = 0.97). 
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the proposed cut-off of <  4.51 µg/dL was identified in 22/58 (38%) of horses at 
some time during hospitalisation; 4/58 (7%) at admission, 5/48 (10%) on day 2, 
10/35 (29%) on day 4 and 14/22 (64%) on day 6.  
    An inappropriately low delta-cortisol < 5.65 µg/dL was identified in 47/58 
(81%) of horses; 32/52 (61%) at admission, 24/42 (57%) on day 2, 12/30 (40%) 
on day 4 and 6/18 (33%) on day 6.  An inappropriately low delta-cortisol < 4.15 
µg/dL was identified in 39/58 (67%) of horses; 26/52 horses (50%) at admission, 
11/42 (26%) on day 2, 7/30 (23%) on day 4 and 4/18 (22%) on day 6. (Table 1 
of paper V) Twelve critically ill horses were diagnosed with RAI/CIRCI (Table 
2 of paper V).  
4.8 Adrenal gland histopathology  
Adrenal gland autolysis occurs rapidly and necropsies typically did not occur 
until 12-36 hours after death, therefore no useful correlations could be made 
between the presence of adrenal gland hemorrhage and necrosis and 
endocrinological test results.  
    The following 3 cases are presented:  
4.8.1 Case number: 1091166 
A 3 year old Tennessee Walking horse gelding presented for colic with a heart 
rate of 60 beats per minute and was estimated to be 8% dehydrated. The horse 
had a SIRS score  = 2. He had 8 litres of nasogastric reflux at admission. 
Serosanguinous abdominal fluid was obtained by abdominocentesis, which had  
a with a normal white blood cell count of 1,600 cells /µL. Rectal palpation 
identified desiccated feed in large intestine and multiple loops of distended 
small intestine. The admission ACTH = 233 pg/mL, cortisol = 55.8 µg/dL (the 
highest cortisol of any patient) and ACTH/cortisol ratio = 4.17.  Due to the 
guarded prognosis and limited finances the horse was euthanized and 






Figure 27a Gross image. There is congestion with blood visible in the vessels  
radiating outward towards the capsule through the zona reticularis and  
glomerulosa. Image courtesy of Dr. Kelly Joiner DVM, PhD, DACVP. 
 
 
Figure 27b. Sub-gross histopathologic image of hemorrhage along the corticomedullary 
junction. There is congestion with blood visible in the vessels radiating outward towards the 
capsule through the zona reticularis and glomerulosa. Image courtesy of Dr. Kelly Joiner 




Figure 27c. Corticomedullary hemorrhage- enlargement. Image courtesy of Dr. 
 Kelly Joiner DVM, PhD, DACVP. 
 
 
Figure 27d Vascular congestion of the corticomedullary region. Vacuolar change  
of the cells of the zona reticularis with lipid droplets and/ or glycogen secondary  
to the stress response. Cells exhibiting this could theoretically be saved/repaired 
but this indicates that they have started down a pathway that ultimately ends in  
apoptosis (cell death/atrophy/necrosis). Image courtesy of Dr. Kelly Joiner DVM, 




4.8.2 Case number: 1091166 
A 14 year old draft horse gelding that presented for colic and had a soft mass 
palpable in the right upper quadrant rectally. The gelding was treated medically 
for ceacal impaction for 4 days then an exploratory laparotomy was performed 
on day 5. A typhlotomy was performed but the cecum ruptured at its base 
during surgery. The horse had a SIRS score of 1 at admission, and cortisol and 
ACTH were only measured at admission (ACTH = 7.6 pg/mL, cortisol  = 5.17 
µg/dL, ACTH/cortisol ratio = 1.47. The horse was not particularly sick over 
the course of hospitalisation with heart rate 56 beats per minute at admission, 
and the heart rate never exceeded 41 beats per minute 
 
 
Figure 28a Gross histopathologic image of hemorrhage: not concentrated at 
corticomedullary junction, rather radiating out from medulla, all the way through  
the cortex, and concentrated in zona glomerulosa. Cortex:medulla ratio is good.  







Figure 28b. Sub-gross histopathologic image of adrenocortical haemorrhage.  




Figure 28c. Adrenocortical haemorrhage with some apoptotic cells.  Image  







Figure 28d. Enlargement of zona glomerulosa haemorrhage.  Image courtesy of 
Dr. Kelly Joiner DVM, PhD, DACVP. 
 
4.8.3 Case number: 109612 
A 15 year old Quarter Horse mare that presented for colic of one days duration. 
She had a heart rate of 80 beats per minute, purplish mucous membranes with a 
2 second capillary refill time. She was estimated to be 10% dehydrated. A cecal 
impaction was identified by rectal palpation. The PCV was 64% and the total 
protein = 6.4 g/dL, with an albumin = 2.6 g/dL. The mare was leukopenic with 
a WBC count = 1,900 cells/µL, and neutropenic with 540 cells/µL. The SIRS 
score = 3. Abdominal fluid was a redish brown and bacteria were observed on 
cytology indicating a ruptured intestine. The horse was euthanized. Admission 
ACTH = 16.8 µg/dL and the ACTH/cortisol ratio = 10.1. A rupture of the base 




Figure 29a.  There were moderate to marked acute multifocal to diffuse  
cortical haemorrhages in both adrenal glands. The cortices of both adrenal  
glands were thin and atrophied (the cortical to medullary ratio was  
approximately 1:6.  Image courtesy of Dr. Richard C. Weiss VMD, 
PhD, DACVP.  
 
 
Figure 29b. Severe adrenocortical haemorrhage.  Image courtesy of  





5.1 Validation of the ACTH stimulation test in healthy 
adult horses (I)  
5.1.1 Maximal adrenal stimulation to low doses of cosyntropin 
Healthy adult horses responded to extremely low doses of ACTH, administration 
of 0.02 µg/kg cosyntropin sufficient to significantly increase serum cortisol 
concentration 30 minutes after injection. As no significant differences were 
detected among maximum cortisol concentrations obtained after administration 
of cosyntropin at doses of 0.1, 0.25, and 0.5 µg/kg the lowest dosage to 
maximally stimulate the adrenal gland was 0.1 µg/kg. Higher dosages of 
cosyntropin resulted in a more prolonged adrenal response. The maximum 
adrenal response was obtained between 30 and 90 minutes after administration 
of 0.1 µg/kg cosyntropin, between 30 and 120 minutes after 0.25 µg/kg, and 
between 30 and 180 minutes after 0.5 µg/kg. The low dose of 0.1 µg/kg was 
selected to try and identify CIRCI in critically ill horses. In previous studies, the 
lowest dose of ACTH administered to adult horses was 0.5 5 µg/kg IV, and this 
dose resulted in cortisol concentrations higher than those obtained after 
maximum exertion during treadmill exercise (Marc et al., 2000; Golland et al., 
1996).  
    When deciding to perform an ACTH stimulation test, the clinician is faced 
with a decision between using a cosyntropin dose high enough to obtain a 
significant increase in cortisol concentration, compared with baseline 
concentration, versus using a dose that will result in a maximum increase. 
Cortisol concentrations 30 minutes after of each of the cosyntropin doses used 
were significantly greater than baseline cortisol and concentrations obtained 
after administration of saline. However, although the 0.02 µg/kg dose resulted 
5 General discussion 
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in a significant increase in cortisol in all 8 horses, it did not cause maximum 
adrenal stimulation, in that peak concentration was lower than peak 
concentrations after administration of the other 3 higher doses. As no significant 
differences were detected in peak cortisol concentrations after administration of 
the 0.1, 0.25, and 0.5 µg/kg doses, we concluded that a dose of 0.1 µg/kg 
cosyntropin with analysis of cortisol concentration at T = 30 and 60 minutes can 
be used to assess maximum adrenal response in healthy horses. Use of a 0.1 
µg/kg dose makes ACTH stimulation testing affordable for use in clinical cases, 
as one vial of cosyntropin (250 µg) is enough to perform five ACTH stimulation 
tests on 500 kg horses do long as the diluted cosyntropin is stored appropriately. 
Reconstituted cosyntropin can be stored in plastic for as long as 4 months in the 
refrigerator or as long as 6 months at –20ºC with no adverse effects on its 
bioactivity (Frank & Oliver, 1988). 
    For ACTH stimulation testing in dogs, there has been a shift from using a 
traditional dose of supraphysiologic dose of 250 µg/dog to using a dose of 5 
µg/kg. The lowest dose of ACTH that causes maximum adrenal stimulation in 
dogs was found to be 0.5 µg /kg (Martin et al., 2007). However the use of this 
lower dose, although more cost effective has not been readily adopted in canine 
practice. Evidence suggests that the lower dose of  0.5 µg /kg is at least as 
accurate and actually appears to be more sensitive at diagnosing CIRCI in 
critically ill dogs is emerging and is in agreement with studies in humans (Martin 
et al., 2010; Soliman et al., 2004; Beishuizen et al., 2000). Although lower doses 
of cosyntropin will result in equal peak concentrations of cortisol as those 
obtained after high dose ACTH stimulation testing, the duration of increased 
cortisol concentrations is reduced when lower doses of cosyntropin are used in 
dogs as we found in horses and foals. Therefore the timing of blood collection 
of the post cosyntropin sample can be performed earlier, but must be more 
precise (Martin et al., 2007; Kerl et al., 1999). 
5.1.2 No change in basal ACTH and cortisol concentrations between 
days  
Mean baseline ACTH and cortisol concentrations did not differ between days of 
the study, ruling out day-to-day variations in environmental effects such as 
temperature, external stimulation, adrenal suppression from repeated ACTH 
administration or acclimatisation to the sampling protocol.  
There was a statistically significant decrease in serum cortisol at T = 240 
minutes after administration of the saline solution that was likely due to a 
reduction in endogenous stress levels. By that time, the horses were accustomed 
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to the procedure, and the environment was quieter at the time of blood sample 
collection. 
5.1.3 Haematological changes in response to ACTH stimulation in adult 
horses 
Statistically significant increases, compared with baseline, were found in the 
neutrophil/lymphocyte ratio at T = 120 minutes after the 0.02 µg/kg cosyntropin 
dose, at T = 240 minutes after the 0.1 µg/kg dose, and at T = 120 and 240 minutes 
after the 0.5 µg/kg dose. There were also increases in the neutrophil and total 
WBC counts 240 minutes after administration of both the 0.25 µg/kg and 0.5 
µg/kg doses. In healthy horses circulating WBCs appear to be sensitive to subtle 
changes in the HPA axis. It is therefore advisable to collect blood for assessment 
of haematological data prior to performing an ACTH stimulation test. There was 
a doubling of the neutrophil/lymphocyte ratio between 0 and T = 240 minutes 
after the 0.25 µg/kg and 0.5 µg/kg cosyntropin doses. There was less variability 
with the 0.5 µg/kg dose, with an increase in the ratio by a factor of 1.5 and 2.4 
times between 0 and  T = 240 minutes. However, due to a lack of consistency 
between individual horses it is not advisable to use haematological parameters 
to assess adrenal responsiveness after cosyntropin administration. If more 
consistent, this would have provided a “stat-lab” assessment of adrenal function. 
In a small previous study a relatively large dose of ACTH (approximately 2 
µg/kg) was administered IV to 3 adult mares, and no significant differences were 
observed in total leukocyte or eosinophil counts at T = 30, 60, 120, and 240 
minutes, compared with values for 4 control mares (Eiler et al., 1979b). 
Differences were potentially not detected in the previous study because of the 
small sample size. 
5.2 Validation of the ACTH stimulation test in healthy 
neonatal foals (II)  
5.2.1 Maximal adrenal stimulation to low doses of cosyntropin  
These results suggested that the lowest cosyntropin dose that can be used to 
assess adrenal gland function in healthy neonatal foals is 0.25 µg/kg, with peak 
cortisol response obtained between T = 20 and 30 minutes after cosyntropin 
administration. There were no significant differences between peak cortisol 
concentrations obtained in response to 0.25 and 0.5 µg/kg cosyntropin doses. In 
a study involving 3 to 4 day old foals, an equivalent increase in cortisol 
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concentrations occurred at T  = 30 minutes after administration of 0.2, 2, and 5 
µg/kg doses of cosyntropin. These authors suggested that a dose between 0.2 
and 2 µg/kg be further evaluated to assess adrenal gland function in neonatal 
foals (Hart et al., 2007). The present study investigated doses intermediate to 
these concentrations. In the study of 3 to 4 day old foals, the peak response to 
the 0.2 µg/kg dose occurred at T  = 30 minutes, returning to baseline 
concentrations by T  = 90 minutes (Hart et al., 2007). In the present study, the 
peak response to the similar dose of 0.25 µg/kg was at T =20 minutes, with 
equivalent responses obtained between T = 10 and 60 minutes. 
5.2.2 Rapid cortisol response to ACTH stimulation adrenal stimulation  
Previous studies in adult horses (Stewart et al., 2011) and 3 to 4 day old foals 
(Hart et al., 2007) have not measured cortisol concentrations at times less than 
30 minutes during an ACTH stimulation test. The study illustrates that the 
adrenal gland response to cosyntropin was very rapid and responses equivalent 
to the peak response occurred as early as T = 20 minutes after 0.25 and 0.5 µg/kg 
cosyntropin administration in the neonatal foals. This rapid response could 
shorten the time required to perform an ACTH stimulation test in healthy foals 
which would be advantageous in a busy clinical situation.  
5.2.3 Lack of response to 0.02 µg/kg of cosyntropin  
Administration of cosyntropin at a dose of 0.02 µg/kg was insufficient to 
increase serum cortisol concentrations in healthy neonatal foals. A similar result 
was found when eight 3 to 4 -day old foals received 1 µg of cosyntropin per /foal 
(approximately 0.02 µg/kg), and no significant increase in cortisol 
concentrations were detected (Hart et al., 2007). Therefore we do not 
recommend using the 0.02 µg/kg dose for clinical testing of adult horses or 
neonatal foals. 
5.2.4 HPA axis in neonatal foals compared to adult horses 
It is essential that reference ranges for adult horses should not be used to assess 
adrenal gland function in foals. Neonatal foals lack a functionally mature and 
responsive HPA axis, and they have a lower cortisol response to exogenous or 
endogenous ACTH compared to adult horses (Hart et al., 2009a; Rossdale & 
Ousey, 1984; Silver et al., 1984). ACTH and cortisol concentrations are highest 
immediately after birth with a gradual decline during the initial week of life (Hart 
et al., 2009a; Wong et al., 2009b). Cortisol concentrations in the 2 to 12 day old 
foals in the present study were similar to those in 3 to 4 day old foals (Hart et 
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al., 2007). It is however very interesting that cortisol concentrations in foals are 
approximately one-third the values in adult horses from paper I (Stewart et al., 
2011). In comparison to the adult horses in paper I, the cortisol concentrations 
post ACTH administration were of lower magnitude, peaked earlier, and were 
of a shorter duration in foals (Stewart et al., 2011).  
    The ACTH concentrations in adult horses from paper I and foals were similar 
(Stewart et al., 2011). However the ACTH concentrations in our study were 
slightly less than reported in other studies of similarly aged healthy foals  (Hart 
et al., 2009a; Wong et al., 2009b), however those studies used a 
chemiluminescent assay while the present study used an immunoradiometric 
assay, which may account for these slight differences (Schott, 2013).  
5.2.5 Haematological changes in response to ACTH stimulation in foals 
compared to adult horses 
In the foals of the present study, the neutrophil/lymphocyte ratio doubled 
between 0 and 120 minutes after administration of the 0.25 µg/kg cosyntropin 
dose, while in adult horses (paper I) the neutrophil/lymphocyte ratio increased 
significantly at T = 120 and 240 minutes after the 0.02, 0.1, and 0.5 µg/kg doses 
compared with baseline (Stewart et al., 2011). The neutrophil and total WBC 
counts increased significantly at T  = 240 minutes after both higher cosyntropin 
doses in adult horses but not in foals (Stewart et al., 2011).  Foals had 
significantly lower lymphocyte counts at T  =  120 minutes after the 0.25 µg/kg 
dose, whereas lymphocyte counts did not change in adult horses (Stewart et al., 
2011). Circulating WBCs are sensitive to very subtle changes in the HPA axis 
in healthy foals and adult horses, with decreases in lymphocyte counts occurring 
in foals and increases in neutrophil counts documented in adult horses. The cause 
of this difference between the age groups is unknown. Similar to adult horses, it 
is advisable to collect blood for assessment of haematologic data in foals prior 
to administering cosyntropin. However, these haematological changes are 
transient and are not considered of any consequence to a healthy foal or a 
critically ill patient, as the ACTH stimulation test even at supra-physiological 
doses is considered safe enough to perform on the most severely ill children 
(Pizarro et al., 2005). For a 50 kg foal   receiving a dose of 0.25 µg/kg dose this 
is a total dose of 12.5 µg of cosyntropin per foal. Critically ill children, dogs and 
even cats have safely received a 250 µg of cosyntropin with no concern for side 
effects (DeClue et al., 2011; Martin et al., 2008; Pizarro et al., 2005). It is likely 
that haematological changes would be more marked, prolonged and consistent 
in high-dose verses low-dose ACTH stimulation tests. This might even allow for 
the use of an indirect “in-clinic” assessment of adrenal function post cosyntropin 
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administration. If the neutrophil/lymphocyte ratio changed consistently after 
administration of a high dose of ACTH in normal animals then this could be 
used to assess adrenal function and bone marrow reserves in ill individuals using 
readily available hospital based benchtop haematological machines at any time, 
without having to measure hormone concentrations, which generally have to be 
performed by “office-hours only” laboratory personnel. Unfortunately, lack of 
consistency among individual foals precludes the use of CBC values to assess 
adrenal gland responsiveness after low dose cosyntropin administration. If 
changes were observed in haematological parameters after cosyntropin 
administration this would be useful, but the sensitivity of this as a diagnostic test 
appears to be low and some false negatives may occur.  
5.3 Insulin dysregulation in horses with systemic 
inflammatory response syndrome (III)  
5.3.1 Relative hypoinsulinemia occurs in horses with SIRS 
Hyperinsulinemia was associated with a favorable outcome indicating a 
functional pancreas, where SIRS associated hyperglycaemia without 
hyperinsulinemia likely indicates pancreatic dysfunction and was associated 
with non-survival. 
    In patients with equine metabolic syndrome (EMS) hyperinsulinemia (either 
chronic or intermittent) is a component of insulin dysregulation and is usually 
associated with a poor prognosis as hyperinsulinemia has been shown to lead to 
laminitis (Bertin & de Laat, 2017; Menzies-Gow et al., 2017; de Laat et al., 
2010; Frank et al., 2010). Although hyperinsulinemia and obesity is well-
described in horses, little was known about the function of the pancreas during 
illness in horses. Experimental LPS infusion resulted in increases in serum 
insulin, and this suggested that hyperinsulinemia occur in acutely sick horses 
(Tadros et al., 2013; Toth et al., 2008; Toribio et al., 2005). In one study LPS 
infusion initially induced a mild decrease in insulin concentration suggesting  
inhibition of pancreatic β cell function before a more pronounced increase in 
insulin (Tadros et al., 2013). In foals, as well as in other species severe systemic 
inflammation has resulted in relative hypoinsulinemia (Barsnick et al., 2011; van 
Waardenburg et al., 2006; Leininger et al., 2000),  where this was defined as a 
failure of insulin secretion in response to SIRS-induced hyperglycaemia. 
Transient diabetes mellitus was described in one foal with severe SIRS (Navas 
de Solis & Foreman, 2010). Our data was in agreement with those reports of 
relative hypoinsulinemia, in that severe hyperglycaemia, with a corresponding 
inadequate insulin response, was associated with non-survival. Although serum 
insulin was higher in survivors, it was rarely above reference range (20 µIU/mL) 
which suggests that rather than excessive insulin secretion in survivors, a 
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decreased insulin secretion was occurring in non-survivors. Therefore in our 
horses with SIRS, hyperglycaemia is likely caused by pancreatic dysfunction 
resulting in decreased insulin secretion and also peripheral tissue insulin 
resistance. 
5.3.2 Hyperglycaemia and hypoinsulinemia were associated with non-
survival indicating endocrine pancreatic dysfunction  
    Hyperglycaemia in horses with colic has previously been associated with poor 
outcome (Hassel et al., 2009; Hollis et al., 2007), and we found similar results. 
Large studies in human critical care units have shown that prolonged 
hyperglycaemia was associated with increased odds of infection, respiratory 
failure, cardiovascular dysfunction, and worse neurological status (Bochicchio 
et al., 2005; Sung et al., 2005; Capes et al., 2000; Suematsu et al., 2000). Causes 
of hyperglycaemia in critically ill patients include stress-associated cortisol 
secretion, hypoinsulinemia, increased gluconeogenesis and peripheral insulin 
resistance (Hassel et al., 2009; Vanhorebeek et al., 2007). In the present study, 
the serum insulin concentrations and glucose/insulin ratio suggest that horses 
with SIRS also have insulin dysregulation, at least partly as a consequence of 
peripheral tissue insulin resistance. In our study, the higher the SIRS score, and 
presumably the sicker the animal, the higher the serum glucose concentration, 
which suggests that the degree of hyperglycaemia could be used to estimate 
severity of SIRS in sick horses. However cautious interpretation is warranted, 
due to our small sample size and that no actual validation of the grouping system 
could be performed. Although, in study, non-surviving horses had a significantly 
larger SIRS score compared to surviving horses (P < 0.05). In human critical 
care serum glucose is used as a prognostic indicator, with associations made 
between specific outcomes and particular blood glucose threshold 
concentrations (Vanhorebeek et al., 2007). However, a single parameter should 
never be relied upon to predict survival, and although serum glucose could be 
used to estimate disease severity, it should not be emphatically used to predict 
survival in sick horses based on its mediocre sensitivity and specificity in our 
sample of horses with SIRS. 
    The insulin/glucose ratio is used to estimate pancreatic β-cell secretion of 
insulin in response to a glycaemic challenge in horses (Bertin & de Laat, 2017). 
In the present study the insulin/glucose ratio was lower in non-survivors 
suggesting pancreatic dysfunction in non-survivors. Although no dynamic 
testing was performed to properly assess pancreatic function in our study, our 
data indicate that horses with SIRS undergo a transient dysfunction of the 
endocrine pancreas. The use of proxies, such as the insulin/glucose ratio, have 
not been fully validated in horses. However, this evidence of pancreatic 
dysfunction may provide an additional method of diagnostic assessment when 
attempting to identify multi-organ dysfunction (MODs) in critically ill horses. 
Pancreatic dysfunction has not  previously been investigated when diagnosing 
MODs in critically ill horses (McConachie et al., 2016).  As the main stimulus 
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for insulin secretion in horses is high blood glucose, our data suggest that in non-
survivors a reduction in insulin responsiveness and decreased insulin sensitivity 
may be responsible for the observed hyperglycaemia (de Laat et al., 2016). A 
low serum insulin in non-survivors indicates a relative hypoinsulinemia and 
(potentially transient) endocrine pancreatic dysfunction. In contrast, although 
consistent with insulin dysregulation, the presence of mild hyperinsulinemia in 
the surviving horses demonstrates an appropriate pancreatic response. Endocrine 
pancreas dysfunction observed in our non-survivors could explain the lack of 
association between serum insulin and glucose those horses. The physiologically 
expected correlation between serum insulin and glucose was only observed in 
our surviving horses. This suggests that, only in survivors, SIRS associated 
hyperglycaemia leads to an appropriate endocrine pancreatic response resulting 
in rebound hyperinsulinemia, and thus limiting the potential deleterious effects 
of sustained hyperglycaemia. In the context of SIRS and critical illness, presence 
of mild hyperinsulinemia might be a good prognostic indicator as it implies an 
adequate endocrine pancreatic response to SIRS-associated hyperglycaemia. 
5.3.3 Hyperinsulinemia and potential development of laminitis 
    In our study, no horse developed laminitis, therefore no conclusion could be 
made on the association between hyperinsulinemia and laminitis in the context 
of SIRS. As both hyperglycaemia and sepsis have been associated with laminitis; 
inflammation associated laminitis would be more likely a manifestation of 
MODs rather than a consequence of acute and mild hyperinsulinemia. Although 
similarities between inflammation-associated and insulin-associated laminitis 
have been documented at a molecular level, the different timings of the processes 
suggest that, if laminitis had been observed in our sample of sick horses, the 
severity of the disease process would have a greater effect on the induction of 
laminitis than the transient and mild hyperinsulinemia observed in our sick 
horses (Bertin et al., 2013; de Laat et al., 2011; Stewart et al., 2009; Stewart et 
al., 1995). In an experimental model, induction of hyperglycaemia was used to 
induce endogenous hyperinsulinemia (insulin = 208 ± 26.1 µIU/L), which was 
sufficient to create subclinical laminitis (de Laat et al., 2012). As our surviving 
horses all had insulin concentrations < 55.2 µIU/mL and the non-survivors < 
24.2 µIU/mL, marked hyperinsulinemia sufficient to lead to laminitis did not 
occur in our patients. Whereas inflammation is one of the underlying causes of 
laminitis in sick horses, we had questioned if hyperinsulinemia in sick horses 
would be one of the underlying causes of laminitis in this population. It seems 
unlikely from our results, but as there were no cases of inflammatory laminitis 
in which insulin was measured this question remains unanswered. 
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5.3.4 Limitations of the study  
Assessment of endocrine pancreatic dysfunction was limited to measurement of 
glucose and insulin concentrations and no dynamic testing was performed during 
the episode of SIRS. As EMS is based on a typical phenotypic presentation (in 
addition to identification of insulin dysregulation) and the majority of horses 
with clinical PPID have hirsutism, there were a few clinical cases of PPID and 
EMS that were excluded from this study. As dynamic tests such as the insulin 
response test, oral glucose test, and ACTH response to thyrotropin-releasing 
hormone stimulation would have been required prior to, or after the period of 
illness to completely rule out subclinical EMS or PPID (de Laat & Sillence, 
2016; Bertin & Sojka-Kritchevsky, 2013; Beech et al., 2011) This study 
involved spontaneous disease in client-owned animals, where survivors were 
discharged from hospital after recovery, it was therefore impossible to perform 
dynamic testing prior to, or (in most cases) after the onset of illness for the 
purpose of this study. There was no evidence of pituitary enlargement in the non-
surviving horses in which a necropsy was performed, suggesting that only a very 
limited number of horses with PPID could have possibly been included in our 
sample population. Further work to validate the effects of dynamic tests of 
endocrine pancreatic function in sick horses could potentially be explored in 
future studies. 
5.3.5 Insulin infusions to control SIRS induced hyperglycaemia and 
potential risk of laminitis 
As recommended in guidelines for human medicine (Jacobi et al., 2012), 
cautious insulin therapy might be of benefit for horses in SIRS presenting with 
severe unregulated hyperglycaemia. Tight glycaemic control through insulin 
infusions and frequent monitoring, with maintenance of serum glucose 
concentrations between 80 – 110 mg/dL (4.4 – 6.1 mmol/L is no longer 
recommended in critically ill humans due to the side effects of inadvertent 
hypoglycaemia (Macrae et al., 2014).  Less stringent conventional glucose 
regulation, such as between 140 – 180 mg/dL (7.8 – 10 mmol/L) through insulin 
infusions resulted in an improvement of outcome with a decreased incidence of 
hypoglycaemia in critically ill humans (Griesdale et al., 2009; Preiser et al., 
2009; Arabi et al., 2008).  
    Our laboratory reference range for blood glucose in horses is 80 – 124 mg/dL 
(4.4 - 6.9 mmol/L), and a continuous rate infusion of insulin could be 
administered to hyperglycaemic critically ill horses in an attempt to control 
blood glucose to within reference range. We routinely do this for hyperlipaemic 
patients with simultaneous infusions of glucose and insulin. Both groups of 
patients are considered insulin resistant, therefore reasonably high dosages of 
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insulin are required to control glucose concentrations than needed in normal 
patients, however the dosages of insulin administered are less than that 
administered experimentally to induce laminitis (de Laat et al., 2010) In dogs 
with diabetic ketoacidosis a dose of insulin of 0.1 IU/kg/hr (by adding 5 IU/kg 
of insulin to a 500 ml bag of 0.9% NaCl (isotonic saline) and administered at 10 
mL/hr is recommend to reduce hyperglycaemia (Dethioux & Goy-Thollot, 
2010). Adding 2 mL of plasma per 50 mL of saline solution prior to adding the 
insulin prevents adhesion of insulin to the synthetic plastic material of the tubing 
and bag (Dethioux & Goy-Thollot, 2010) I have used this dosage in 
hyperlipaemic ponies and critically ill neonatal foals that are receiving 
intravenous dextrose or partial or total parenteral nutrition to control 
hyperglycaemia by forcing glucose uptake by peripheral tissue. Glucose 
concentrations are measured every 4 hours and if the animal becomes 
hypoglycaemic the rate of the insulin infusion is decreased, while if the animal 
becomes hyperglycaemic the rate of glucose infusion is decreased. This dose is 
approximately one quarter of that used to induce laminitis experimentally in non-
insulin resistant (normal) horses and ponies (personal observation). Laminitis 
has been experimentally induced by administration of a bolus of 45 mIU/kg of 
insulin followed by a constant rate infusion of 6 mIU/kg/minute (0.36 
IU/kg/hour) with a glucose infusion administered at a variable rate to ensure 
euglycaemia (euglycaemic-hyperinsulinemic clamp technique). This resulted in 
massive serum insulin concentrations > 1000 µIU/mL (de Laat et al., 2010). 
    In another experimental study in which mild hyperglycaemia (10 ± 0.78 
mmol/L) was induced by administration of 50% dextrose over 48 hours at a rate 
of 0.68 mL/kg/hr (with reductions in the infusion rate of 10% if serum glucose 
exceeded 15 mmol/L), endogenous hyperinsulinemia (insulin = 208 ± 26.1 
µIU/L) was created which induced lamellar lesions but not foot pain (de Laat et 
al., 2012). Therefore although experimental super-physiologic infusions of 
insulin can induce laminitis, prolonged experimental hyperglycaemia also 
induces sub-clinical lamellar changes. Thus leaving equine patients in a 
hyperglycaemic state is also potentially a risk factor for laminitis. Therefore, in 
addition to commencing with the protocol used for ketoacidotic diabetic dogs, 
daily measurement of serum insulin concentrations in equine patients to ensure 
that they remain well below 50 µIU/L during the infusions would be advisable. 
More research documenting the use of insulin infusions in non-terminal 
hyperglycaemic equine critical care cases with serial monitoring of serum 
insulin concentrations is warranted (Figure 30). It would also be interesting to 
prospectively examine insulin and glucose concentrations in critically ill horses 
that develop laminitis; however with supportive care including digital 
hypothermia and use of anti-inflammatory drugs the incidence of laminitis 
appears to have reduced (personal observations). Over the last 20 years, having 
worked in various regions with differing equine population and diseases, the 
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variation in incidence in laminitis observed by this author is likely a reflection 
of the multifactorial aspects of genesis of laminitis.  
5.4 Cortisol and ACTH concentrations in horses with 
systemic inflammatory response syndrome (IV)  
5.4.1 The stress response in horses with SIRS 
ACTH and cortisol concentrations were significantly higher in non-surviving 
horses and those with an ischemic gastrointestinal lesion. This was not 
unexpected, as the presence of an ischemic gastrointestinal lesion and non-
survival are indicative of more severe disease processes, and this is compatible 
with a physiologic response to stress. The ACTH/cortisol ratio was 
significantly higher in non-surviving horses, horses with SIRS and those with 
ischemic lesions. The high ACTH/cortisol ratio indicated that the magnitude of 
the pituitary response was greater than that of the adrenal response, and may 
suggest possible RAI/CIRCI (Gold et al., 2007).   
    Equine emergency patients experience stress from fear, pain, dehydration, 
inappetence and the consequences of systemic inflammation such as fever, 
hypotension or hypoxemia. Factors shown to affect CRH secretion in a variety 
of species include cytokines, lipopolysaccharide, (brain-derived neurotropic 
factor, neurosteroids, glutamate, γ-aminobutyric acid, nitric oxide and through 
 
 
Figure 30. A post-operative patient in the equine intensive care unit receiving high 
volume intravenous fluid therapy in conjunction with a glucose and insulin infusion. 
 Photos: A.J. Stewart. 
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the negative feedback effect of glucocorticoids (Dembek & Toribio). 
Lipopolysaccharide was detected in 29% of horses presenting for colic, and is 
more commonly detected in horses with ischemic gastrointestinal lesions 
(Senior et al., 2011). Interleukins-1β, -6 and -8 mRNA expression have been 
shown to be upregulated in surgical colic patients (Epstein et al., 2016).   
Although neurosteroids have been measured in critically ill foals, the direct 
effect of various other inflammatory mediators on the HPA axis of sick horses 
has not been investigated. Arginine vasopressin and CRH stimulate release of 
ACTH from corticotropes in the pituitary pars distalis, and this is moderated 
by cytokines, lipopolysaccharide, nitric oxide and glucocorticoids during 
illness (Dembek & Toribio). Although we did not assess CRH or vasopressin 
concentrations in this study, the prevalence of ACTH hyposecretion or 
hypothalamic dysregulation in relation to HPA axis dysfunction is low 
compared to adrenocortical failure in humans and septic foals (Annane et al., 
2018; Hurcombe et al., 2008).  
5.4.1 Association between ACTH and survival 
Studies assessing ACTH concentrations in sick adult horses are sparse, with 
mean ACTH concentrations being 2.4 times higher in 43 horses with colic 
compared to normal controls, with the highest values occurring in horses with 
strangulation of the small or large intestine (Ayala et al., 2012). Similarly, we 
found that ACTH was significantly higher in horses with ischemic 
gastrointestinal lesions than those without. The median ACTH concentration in 
non-surviving horses was 3.6 times higher than in normal horses (from our 
institution measured with the same assay (Funk et al., 2011)). However, 
individual variation in the sick horses was extreme, with the highest ACTH 
value occurring in a surviving horse, which was 49 times higher than normal 
horses. When ACTH concentrations were within reference range at either 
admission or on day 2, this was associated with a higher odds ratio of survival. 
5.4.2 Clinical implications for testing for PPID in horses that have 
recovered from illness 
Although the pituitary gland has a high capacity to increase ACTH production, 
in surviving animals this response was rapidly normalized, as over 90% of horses 
had an ACTH concentration within reference interval prior to patient discharge. 
This has clinical implications for the diagnosis of PPID. If PPID is suspected in 
an older hospitalized horse testing for PPID may be recommended prior to 
patient discharge. In the present study, ACTH concentration was normal in 
95/103 (92%) of horses at the time of patient discharge, with 5 horses having an 
ACTH between 28-40 pg/mL and only 3 horses having an ACTH concentration 
between 60-110 pg/mL. Therefore at the time of patient discharge ACTH testing 
for PPID could be reliably performed in 92% of cases. Therefore if there was 
concern about a differential of PPID in a horse that had recovered from illness, 
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then collection of plasma to measure ACTH concentration for the purpose of 
diagnosing PPID, could be performed prior to discharge, or at least the horse 
could be hospitalized for a further day prior to sample collection. There would 
only be an 8% chance of a false positive result it testing was performed on the 
day of discharge. 
    There is reemerging concern about the stability of equine ACTH (Bertin et 
al., 2018b). Our current recommendation is to chill samples immediately,  
remove plasma by centrifugation within 2 hours and analyse a non-previously 
frozen sample within 8 hours of collection, because of the high proportion of 
misdiagnoses that can occur due to unpredictable deceases and increases in 
measured ACTH concentrations with less than ideal sample handling procedures 
which can result in false positive and negative diagnoses of PPID (Bertin et al., 
2018b). Therefore measurement of ACTH concentrations in some situations will 
be best performed at institutions with onsite laboratories rather than shipping 
samples overnight from remote private practices or batch freezing samples prior 
to analysis. Based on the results from the current study (paper IV), there would 
only be an 8% chance of a false positive result for the diagnosis of PPID if testing 
was performed on the day of patient discharge after recovery from illness, which 
is actually lower than the number of misclassifications that were identified in the 
diagnosis of PPID when samples were mishandled (Bertin et al., 2018b). 
5.4.3 Comparison of ACTH concentrations in sick adult horses to foals 
In comparison to foals, adult horses tend to have lower ACTH concentrations, 
but ACTH is higher in septic compared to healthy foals and higher in non-
survivors than survivors (Stewart et al., 2013; Hurcombe et al., 2008; Gold et 
al., 2007). As measured ACTH concentrations vary when using different 
analytical methodologies, it is difficult to directly compare actual values 
obtained in different studies. The Scantibodies™ immunoradiometric kit used 
in the present study has been shown to be highly accurate, but measures 3.6-
fold lower than the chemiluminescent Immulite™ (Schott, 2013). 
5.4.4 Association between cortisol and survival  
The zona fasciculata in the adrenal cortex secretes glucocorticoids (cortisol), 
which decrease CRH, vasopressin and ACTH secretion by negative feedback. 
Cortisol increases gluconeogenesis, decreases glucose utilization, increases 
serum glucose and inhibits the effects of insulin. Cortisol concentrations were 
increased for each of our three outcome variables (non-survival, presence of 
SIRS or ischemic gastrointestinal lesion). These findings were supported by 
previous studies in horses with colic (Ayala et al., 2012; Hinchcliff et al., 
2005). Mair showed that horses with colic are more likely to have a serum 
cortisol > 7.25 µg/dL than healthy controls, that cortisol is higher in colic 
patients with a heart rate > 45 beats per minute, and that horses with a higher 
cortisol demonstrate more severe signs of colic, although a direct association 
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between high cortisol and survival was not detected due to wide individual 
variations in cortisol concentration in both survivors (2.8 to 47.6 µg/dL) and 
non-survivors (5.1- 38.8 µg/dL) (Mair et al., 2014).  
5.4.1 Comparison of cortisol concentrations in sick adult horses to foals  
Our previous work comparing normal 2-12 day old foals and adult horses 
showed that baseline cortisol values are lower in normal neonatal foals than 
adult horses, but adult horses appear to have a greater adrenal capacity and 
reserve than neonatal foals to produce and release cortisol after exogenous 
ACTH stimulation (Stewart et al., 2013; Stewart et al., 2011). This also 
appears to be true in illness, with our sick adult horses generally having higher 
cortisol concentrations than those observed in septic neonatal foals (Hurcombe 
et al., 2008; Gold et al., 2007). 
5.4.2 Limitations of immunoassays compared to liquid–chromatography 
mass spectrometry  
Our previous work comparing normal 2-12 day old foals and adult horses 
showed that baseline cortisol values In humans with septic shock, routinely 
used immunoassays for total cortisol appear to correlate poorly (inter-assay 
variations in up to 27% of cases), when compared to the gold standard of 
liquid–chromatography mass spectrometry (LC-MS). Unfortunately LC-MS is 
time and labor intensive and not available for clinical cases at most institutions 
(Bornstein, 2009; Briegel et al., 2009) Although there are limitations in the use 
of immunoassays to measure cortisol and ACTH concentrations, standardized 
sample handling procedures for samples and looking at trends and relative 
changes in hormone concentrations measured on same assay from the same 
institution are likely to be valid.  
5.4.3 Scoring systems for severity of illness and clinical implications 
equine for colic patients 
There is no accepted grading scheme to categorize the severity of illness in sick 
adult horses, although a scoring system for multiple organ dysfunction in 
equine surgical patients has recently been developed (McConachie et al., 
2016). Sepsis is a common cause of hospitalisation in neonatal foals, and 
several scoring systems have been compared to categorize the severity of 
illness in septic foals or assess the likelihood of survival, which allows 
reasonable comparisons of illness severity between various research studies 
(Wong et al., 2018; Dembek et al., 2014). We have utilized the number of 
SIRS criteria to try and objectively categorize the severity of illness in sick 
adult horses (Bertin et al., 2018a) Although the median SIRS score was higher 
in non-survivors than survivors, there was only a trend for the SIRS score to be 
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higher in horses with ischemic lesions compared to those with non-ischemic 
lesions. SIRS score may not be the best method to classify the severity of 
illness in equine colic cases. The presence of an ischemic lesion in a colic case 
will be fatal unless surgically removed, but the severity of illness at patient 
admission is reflected by the location, extent and duration of the area of 
devitalised bowel and by any supportive treatments such as fluid therapy, 
analgesics, anti-inflammatories and endotoxin binders.  
5.4.4 Clinical implications of using cortisol and ACTH as a predictors of 
survival  
In severely ill humans, the APACHE II score has been used within 24 hours of 
patient ICU admission to assess illness severity and risk of death (Knaus et al., 
1985) However the day 2 cortisol concentration was a better discriminator of 
ICU patient outcome with a predictive ability of 81%, while the APACHE II 
score had a predictive ability of only 70% (Rothwell & Lawler, 1995; Jarek et 
al., 1993). The use of cortisol, ACTH and ACTH/cortisol ratios as predictors 
of survival has not been previously assessed in a large group of horses admitted 
to an equine emergency service. Although no single factor should ever be used 
to predict survival of individual cases, and experienced clinicians have been 
shown to be better predictors of survival than soring systems, (Rohrbach et al., 
2006) the relative importance of these factors and potential clinical 
implications should be considered. Although many studies have investigated 
admission clinicopathologic findings to assess likelihood of survival, in many 
cases changes over time in patients surviving the initial admission period (or 
those not euthanized due to a poor prognosis, inhumanity or lack of financial 
resources to justify the high costs involved in critical care of the equine patient) 
are more important. We attempted to assess cortisol and ACTH concentrations 
over 6 days of hospitalisation, but many non-severely ill horses were 
discharged prior to day 6, whereas the majority of our non-survivors were 
euthanized within the initial 24-hours, with only 11 non-survivors available for 
testing on day 2. Thus the study lacked sufficient power to detect if there was a 
difference in cortisol or ACTH concentrations between survivors and non-
survivors on days 2, 4 and 6 of hospitilisation. At patient admission many 
factors beyond the effects of illness may affect ACTH and cortisol 
concentrations such as fear from transportation, a foreign indoor environment, 
rapidly moving support personnel and venipuncture in addition to effects of 
sedation and analgesics. Blood samples were collected prior to hospital 
administration of any medication but there was no attempt to make allowances 
for distance travelled or pre-admission medication, although none of the horses 
appeared to be sedated. Mair previously found that the effect of transport was 
not a significant confounding factor influencing cortisol concentrations in 
horses with colic (Mair et al., 2014) When investigating effects of spontaneous 
disease in admitted patients these factors cannot be controlled, but are 
representative of a typical clinical scenario.  
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5.4.5 Inter-relationships between the HPA axis and insulin/glucose 
dynamics  
In severe illness, SIRS, sepsis, shock and multiple organ dysfunction occurs 
resulting in loss of physiologic hemostatic mechanisms. Cortisol should inhibit 
insulin in order to raise serum glucose concentrations, but hyperglycaemia has 
shown to be a poor prognostic indicator in horses with colic (Hassel et al., 
2009). We have recently shown that hyperinsulinemia and hyperglycaemia are 
both common in equine patients diagnosed with SIRS, but that horses with 
relative hypoinsulinemia and corresponding hyperglycaemia have a worse 
prognosis, due to suspected endocrine pancreatic insufficiency (Bertin et al., 
2018a). 
5.4.6 High ACTH/cortisol ratio as an indicator of adrenal dysfunction   
Pituitary reserve and ability to release large amounts of ACTH with the stress 
of illness appears to be greater in horses than the corresponding capacity for 
adrenal production and release of cortisol, resulting in a high ACTH/cortisol 
ratio, and has been defined as ACTH-cortisol imbalance (Dembek et al., 2017). 
In cases when the cortisol release is inadequate for the degree of illness 
because of adrenal gland dysfunction, then a diagnosis of RAI/CIRCI can be 
made. Although the ACTH/cortisol ratio is not as accurate as results from an 
ACTH stimulation test, it is easy to perform, less expensive and has provided 
useful information in critically ill foals (Hart et al., 2009b; Wong et al., 2009a; 
Gold et al., 2007). Our results showed that the ACTH/cortisol ratio was higher 
in non-survivors, horses with SIRS and those with ischemic lesions. This was 
similar to results found in some studies involving septic foals where the 
ACTH/cortisol ratios were significantly higher in septic foals than sick-non-
septic or normal foals (Dembek et al., 2017; Gold et al., 2007). The actual 
value of the ratio was much higher in foals compared to adult horses because 
healthy and sick foals tend to have a higher ACTH and lower cortisol 
concentrations than adult horses (Stewart et al., 2013; Stewart et al., 2011) An 
appropriate cortisol concentration in response to illness of varying severities 
has not previously been defined for adult horses. In humans and foals a low 
baseline cortisol concentration or an inadequate response to a high or low dose-
ACTH stimulation test have been advocated as means to diagnose CIRCI 
(Annane et al., 2018; Hart et al., 2009b; Wong et al., 2009a)  
    As seen in this study, the most common reason for emergency hospital 
admission for horses is colic, with ischemic bowel requiring prompt surgical 
intervention under general anesthesia. Inflammation, shock, coagulation 
disorders, ischemia/reperfusion injury, SIRS and ileus are common syndromes 
requiring multimodal medical therapy in colic patients. Although ACTH and 
cortisol are significantly higher in horses with ischemic gastrointestinal lesions 
and non-surviving horses, the ACTH/cortisol ratio was significantly higher in 
non-surviving horses, horses with SIRS and those with ischemic lesions. The 
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high ACTH/cortisol ratio may indicate pituitary-adrenal dysregulation or an 
inadequate cortisol response to the stress of illness suggesting possible 
RAI/CIRCI(Gold et al., 2007) Further investigation is required to determine if 
low-dose glucocorticoid therapy is beneficial in improving survival in a subset 
of adult equine intensive care patients.  
5.5 Identification of adrenal dysfunction in critically ill 
adult horses  
5.5.1 Summary of findings 
Similar to our findings in project (IV) which included a much larger group of 
horses, the basal concentrations of ACTH and cortisol were statistically higher 
at admission in non-survivors than survivors in this group of equine hospital 
emergency admissions. Although horses with ischemic gastrointestinal lesions 
had statistically higher basal cortisol concentrations at admission than those 
without ischemic lesions, those with ischemic lesions failed to respond to a 
low-dose ACTH stimulation test. In contrast, horses without an ischemic lesion 
did respond, with higher cortisol concentrations at T = 30 minutes after 
cosyntropin administration compared to basal cortisol. Similarly, there was a 
tendency for non-surviving horses to fail to respond to the low-dose ACTH 
stimulation test compared to surviving horses. Adrenal insufficiency was 
diagnosed in 12 critically ill horses fulfilling our criteria for RAI/CIRCI.  
5.5.2 A diagnosis of CIRCI must only be made in critically ill horses  
Many more horses had a low basal or delta-cortisol concentrations at various 
times throughout hospitalisation and this was considered adrenal dysregulation. 
Although all these cases were sick, they were not all considered to be critically 
ill, and hence not classified as CIRCI cases. CIRCI only occurs by definition, 
in critically ill patients (Annane et al., 2018). However, many of our cases 
certainly did have cortisol or delta cortisol concentrations less than not only 
what was expected for their degree of illness, but in many cases, less than that 
of normal quiet teaching horses (Stewart et al., 2011). Therefore this is 
considered to be due to some degree of adrenal dysregulation. However, a 
numerically low basal-cortisol or poor response to ACTH stimulation should 
not be considered on its own as a defining criteria for a diagnosis of CIRCI in 
all horses admitted to a referral emergency service.  
    Adrenal insufficiency is considered common in human patients with sepsis, 
septic shock, severe trauma and acute respiratory distress syndrome, however 
the incidence is dependent on the population studied and the diagnostic test and 
criteria used to make the diagnosis (Annane et al., 2018). Although all equine 
cases included in this study were presented to referral hospitals as emergency 
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admissions, the severity of illness varied greatly, and the numerical cut-offs 
used for an inappropriately low cortisol may not have been appropriate for 
horses with relatively mild illness such as impactions of the small and large 
colon, or large colon displacements that did not have any ischemic lesions. 
However, why their cortisol concentrations were lower than normal non- 
stressed horses requires further investigation. 
5.5.3 Defining a cut-off value for an inappropriately low basal cortisol 
concentration in critically ill patients  
Mean basal cortisol in surviving human ICU patients was 27 µg/dL, compared 
to 47 µg/dL in non-survivors, with cortisol found to be an independent 
predictor of outcome (Rothwell & Lawler, 1995). Others have found mean 
cortisol in human patients with septic shock to average 50 µg/dL (Marik & 
Zaloga, 2002). Although there has been no direct comparison of the adrenal 
capacity of horses compared to humans, the values we obtained in surviving 
and non-surviving ICU horses were lower. The maximum cortisol 
concentration was 55.9 µg/dL in a non-surviving horse. However all our 
patients were ambulatory and unlikely to be as sick as human or neonatal foal 
ICU patients with septic shock. Compared to neonatal foals, septicemia is 
uncommon in adult horses, and although traumatic septic arthritis is common, 
these horses are rarely systemically ill and were not included in the sick horse 
population in this study. Our population included mostly colic cases with 
ischemic and non-ischemic gastrointestinal lesions, with a lower number of 
critically ill horses with colitis and pleuropneumonia. Therefore, we were 
interested in the outcome variables of ischemia, SIRS and survival rather than 
sepsis or septic shock as has previously bene described in neonatal foals (Hart 
et al., 2009b; Wong et al., 2009a).    
    There is still a lack of consensus, even among a panel of experts, as to the 
best methods to diagnose CIRCI in humans (Annane et al., 2018).  Marik 
suggested that random cortisol concentrations < 25 µg/dL in highly stressed 
patients was useful to diagnose adrenal insufficiency and substantiate 
hydrocortisone therapy (Marik & Zaloga, 2003). The European CIRCI 
guidelines suggest using either a random endogenous cortisol of < 10 µg/dL or 
a delta-cortisol of < 9 µg/dL after intravenous administration of 250 µg 
cosyntropin (high-dose ACTH stimulation test) (Annane et al., 2018). Patients 
diagnosed as having CIRCI using these criteria had poorer outcomes than those 
without CIRCI (Annane et al., 2018).   
5.5.4 Defining a cut-off value for an inappropriately low basal cortisol 
concentration in critically ill adult horses  
In healthy unstressed adult horses we previously found a basal cortisol of 6.15 
± 1.63 µg/dL (Stewart et al., 2011). However, sick animals should have higher 
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cortisol concentrations than healthy animals. To simulate a physiologically 
stressed basal cortisol, Hart used the lowest (mean – 1 SD) cortisol 
concentration obtained after administration of cosyntropin to healthy foals to 
define a cut-off value for an appropriate basal cortisol concentration in sick 
foals (Hart et al., 2009b). Using this definition, Hart found that 46% of 
hospitalized foals had inappropriately low basal cortisol (however not all of 
these foals were septic or critically ill). Using the same definition, using data 
from normal adult horses, this results in a cut off value in sick adult horses for 
an inappropriately low basal cortisol concentration of < 9.7 µg/dL. In our 
study, the number of hospitalized adult horses with basal cortisol < 9.7 µg/dL, 
was 55% at admission, 79% on day 2, 94% on day 4 and 100% on day 6. 
However, this is likely too high a cut-off value and not useful as diagnostic 
criteria for diagnosing RAI/CIRCI in sick hospitalized adult horses. Therefore I 
elected to use a far more conservative approach, by using a basal cortisol 
concentration less than the lowest (mean -1SD) obtained from normal horses to 
define an inadequate basal cortisol in sick horses with a cut-off value of < 4.51 
µg/dL, which was identified in 45% of horses; 7% at admission, 10% on day 2, 
29% on day 4 and 64% on day 6. The high number of sick horses with basal 
cortisol concentrations less than the lowest basal cortisol concentration 
detected in healthy (quiet temperament university owned) horses was a 
surprising finding. Also, that the proportions of horses with an inappropriately 
low basal cortisol concentration increased throughout hospitalisation was even 
more interesting. By day 6 the sickest horses were dead and the healthiest 
horses had been discharged. The remaining horses were relatively 
compromised cases, and therefore possible explanations include adrenal 
structural damage, utilization of cholesterol substrate to synthesise cortisol, 
adrenal exhaustion, or negative feedback from previously elevated cortisol 
concentrations.  
5.5.5 Defining a cut-off value for an inappropriately delta cortisol 
concentration in critically ill patients  
Traditionally, the dynamic high-dose ACTH stimulation test is used to 
diagnose absolute adrenal insufficiency (Addisons’s disease), in which 
supraphysiological doses of ACTH are administered, e.g. one entire vial of 
synthetic ACTH which is 250 µg /human patient or approximately 2-5 µg/kg. 
This dose creates ACTH concentrations 100-fold greater than secreted 
endogenously in response to stress (Oelkers, 1996). Critically ill patients are 
considered to have relative rather than absolute adrenal insufficiency, and a 
normal response to a high-dose ACTH stimulation test does not rule out 
RAI/CIRCI, as RAI is believed to be partly due to adrenal resistance to ACTH. 
A supraphysiologic dose of ACTH can override adrenal resistance to ACTH, 
resulting in a normal cortisol response in some cases (Oelkers, 1996). Although 
the high-dose ACTH stimulation test has remained the most popular, the 
physiologic low-dose (1-2 µg/human) ACTH stimulation test was introduced 
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to increase the test sensitivity. It appears more sensitive at diagnosing 
early/mild cases of RAI/CIRCI, (Soliman et al., 2004) and accordingly, has 
been recommended by some as the preferred test (Gonc et al., 2003; 
Beishuizen et al., 2000). One randomized trial showed that the low-dose (1 µg) 
ACTH test was better able to predict the longer duration of vasopressor 
dependence and the hemodynamic response to hydrocortisone in septic shock 
patients than the high-dose ACTH test or a random basal cortisol < 25 µg/dL, 
in extremely ill people with a mortality rate of 47% (Marik & Zaloga, 2003).  
A prospective study with 74 septic shock patients showed that the high and 
low-dose ACTH stimulation tests were equally accurate in predicting 
dependency on vasopressors and mortality (Moraes et al., 2012).   
    The latest European CIRCI guidelines suggests to utilize high-dose rather 
than low-dose ACTH stimulation to diagnose CIRCI, but the main reason was 
due to convenience (Annane et al., 2018). The high-dose test is safe and easy 
to perform, as an entire vial of cosyntropin is used. The European task-force 
stated that the major disadvantage of the low-dose test was that it required 
additional preparation to dilute the ACTH.  (This was a surprising 
recommendation as syringing reconstituted cosyntropin using the same 10 ml 
syringe used in the reconstitution process into a 250 mL bag of 0.9% NaCl and 
doing a basic mathematical calculation is really not that difficult!) Equal 
efficacy (or increased sensitivity as shown in some studies); decreased 
physiological effects of the test itself (haematological changes); and lower cost 
all provide reasons to perform the low-dose ACTH stimulation test in 
preference to the high-dose test. In human medicine there is a huge amount of 
medical waste and inefficiency. Diluted cosyntropin in a now unsealed bag of 
0.9% NaCl would be unlikely be allowed to be saved for future testing on 
additional patients, even if sterilely prepared and appropriately stored.  
5.5.6 Defining a cut-off value for an inappropriately delta cortisol 
concentration in sick adult horses  
As the 0.1 µg/kg dose of cosyntropin was shown to result in maximal adrenal 
stimulation in healthy horses compared to 0.25 and 0.5 µg/kg, we elected to 
utilize this low-dose, with post cosyntropin cortisol sample collected after 30 
minutes to correspond with the peak cortisol response. The mean ± 1SD delta-
cortisol was 5.65 ± 1.50 µg/dL 30 minutes after 0.1 µg/kg (Stewart et al., 
2011).  Higher doses of cosyntropin result in a more sustained adrenal 
stimulation, which would allow post cosyntropin samples to be collected over a 
wider testing window (Stewart et al., 2011). However, at a dose of 0.1 µg/kg, 
one 250 µg vial of cosyntropin is sufficient to perform five ACTH stimulation 
tests on 500 kg horses, making the test affordable even for large equine 
patients. Due to the large range of body weights of horses, we elected to also 
use a µg/kg dose rather than a µg/horse dose.  
    Utilizing a variation of Hart’s formula, we defined an inappropriate delta-
cortisol response to a low-dose ACTH stimulation test as a value less than the 
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mean delta-cortisol obtained from healthy horses 30 minutes after 
administration of 0.1 µg/kg of cosyntropin, which was a delta-cortisol < 5.65 
µg/dL (Stewart et al., 2011; Hart et al., 2009b). We also described a more 
conservative cut-off value of less than the mean -1SD delta-cortisol obtained 
from healthy horses, with a value of < 4.15 µg/dL. Hart found that 52% of 
hospitalized neonatal foals had inadequate delta-cortisol after a high-dose 
ACTH stimulation test, with the latter being significantly correlated with 
shock, multiple organ dysfunction (MODS) and decreased survival in one 
subset of septic foals. A low delta-cortisol response to a low-dose ACTH 
stimulation test was correlated with an increased risk of MODS but not shock 
(Hart et al., 2009b). Overall, we found that horses with an ischemic 
gastrointestinal lesion had a poor response to a low-dose ACTH stimulation 
test, compared to those without an ischemic lesion. An inappropriately low 
delta-cortisol using a cut-off value < 5.65 µg/dL was identified in 81% of 
horses, while the more conservative cut-off of < 4.15 µg/dL was identified 
67% of horses, with 50% at admission, 26% on day 2, 23% on day 4 and 22% 
on day 6. It is unknown which of these horses would have benefited from 
glucocorticoid therapy to moderate inflammatory responses or assist in blood 
pressure regulation.  
5.5.7 Diagnosis of RAI/CIRCI in critically ill horses  
When combined with clinical judgement of severity of illness in addition to 
either a low basal cortisol or low delta-cortisol (using the most conservative 
cut-off values), there were 12 horses ultimately diagnosed with RAI/CIRCI and 
only 10 survived. It is interesting that the two surviving cases were both colitis 
cases with SIRS and they both had basal cortisol concentrations lower-than-
expected for illness or even lower than normal horses on all 4 test days. 
However, when low-dose ACTH stimulation tests were performed, they both 
had adequate delta-cortisol concentrations. In contrast, of the 10 horses that 
were euthanized due to a variety of severe conditions and were diagnosed with 
RAI/CIRCI due to an inadequate response to the low-dose ACTH stimulation 
test on at least on occasion, only 2 of these had low basal cortisol 
concentrations. Six of these cases were euthanized within the initial 24 hours 
and therefore endocrine testing was performed only once. Of the 3 non-
surviving cases that had endocrine testing performed on 3 or 4 occasions, two 
of these had an inadequate response to ACTH stimulation on multiple 
occasions. Endocrine testing on day 2 of hospitalisation would eliminate 
having to test horses with rapidly fatal conditions and remove the influences of 
transport, sedation and dehydration, but vast numbers of critically ill horses 
would need to be enrolled to make any definitive recommendations as to the 
usefulness of performing ACTH stimulation and to refine appropriate cut-off 
values to diagnose RAI/CIRCI in critically ill adult horses. 
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5.5.8 Hypotension in CIRCI patients and considerations in our horses 
Although not all human patients with septic shock have CIRCI, arterial 
hypotension refractory to fluid resuscitation and vasopressor support is one 
potential marker for inadequate glucocorticoid activity (Annane et al., 2018).  
Many of our patients were likely experiencing hypovolemic shock, and some 
septic shock, but as assessment of blood pressure was not routinely performed, 
it was impossible to quantify in this study. Within 10 minutes of hospital 
admission clinically dehydrated animals would have been receiving high 
volume intravenous fluid therapy, but none were administered vasopressors 
prior to or after anesthesia. Administration of low dosages of glucocorticoids 
results in improvement of blood pressure in many cases of CIRCI, but also in 
non-CIRCI patients with septic shock, however patients with CIRCI had a 
poorer prognosis (Annane et al., 2018; de Jong et al., 2015; Sprung et al., 
2008).  Due to the large numbers of patients required to determine the 
usefulness of low-dose glucocorticoid therapy and relevance to 
endocrinological test results in human medicine, and the conflicting results 
obtained between studies (Annane et al., 2018), it is unlikely that such a study 
with sufficient power could be undertaken in critically ill horses to definitively 
prove the usefulness of glucocorticoids to help improve hypotension in 
standing or anaesthetized critically ill adult horses.  
5.5.9 Glucocorticoid administration to CIRCI patients, side effects and 
the necessity for endocrinological testing 
Inadequate cortisol mediated anti-inflammatory activity for the severity of 
illness is considered a defining feature of CIRCI. Meta-analysis of 27 
randomized clinical trials with 3176 patients with sepsis (with and without 
shock), found a higher 28-day mortality (31.8%) in patients receiving a placebo 
compared with patients receiving corticosteroids (29.3%), with a relative risk 
of 0.87 [95% CI = 0.76 – 1.0] (Gibbison et al., 2017). There was no increase in 
the rate of secondary infections and the most common adverse event was 
hyperglycaemia (Gibbison et al., 2017).  In human medicine the current 
recommendation is to administer low-dose corticosteroids to hospitalized 
patients with septic shock that are not responsive to fluid therapy and moderate 
to high-dose vasopressor therapy, but not to patients with sepsis alone (Annane 
et al., 2018). As endocrinological testing has been shown to have a poor 
sensitivity and specificity for determining which patients will benefit from 
low-dose glucocorticoid administration, the recommendation is to treat based 
on clinical judgement rather than to await results of endocinological testing 
(Annane et al., 2018; Sprung et al., 2008) Prior to the commencement of this 
body of work, the recommendation was to perform ACTH stimulation testing 
on patients and then immediately commence glucocorticoid therapy if 
clinically indicated and then discontinue glucocorticoid therapy if results of 
endocrinological testing were normal (Annane, 2005). Treatment with low-
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dose glucocorticoids in critically ill horses should be based on endocrinological 
testing until more information becomes available about the response to 
treatment in this group of patients. Eventually a large randomized, blinded, 
multicenter study would be required to determine if horses with or without 
CIRCI (based on inappropriately low basal or delta corticol concentrations) 
had differences in responses (positive and negative) after treatment with low-
dose glucocorticoids.  
5.5.10 Potential use and risks of glucocorticoids in horses with CIRCI  
Although there has been no deleterious effects of low or moderate dose 
glucocorticoid therapy in human patients with septic shock, it is still unknown 
if empiric low-dose corticosteroid therapy would be useful or detrimental in 
critically ill horses. The specific criteria for recommendation of glucocorticoid 
therapy in critically ill horses is still uncertain, but could be possibly be 
considered in those with SIRS and MODs and certainly in those with 
unresponsive hypotension. However these horses are also at risk of laminitis 
(Parsons et al., 2007). The relationship with prior administration of 
glucocorticoids and laminitis development is still hotly debated (Cornelisse & 
Robinson, 2013; Bailey & Elliott, 2007; Dutton, 2007; Johnson et al., 2002). 
Although there are anecdotal results of laminitis occurring after administration 
of glucocorticoids in critically ill horses (Dr. Sally Church BVSc, FANZCVS, 
1997) there are no published studies. Certainly there is a higher risk of 
laminitis with high dosages and prolonged courses of corticosteroids especially 
triamcinolone, potentially because of its induction of prolonged 
hyperglycaemia and hyperinsulinaemia (French et al., 2000).  
    In a study involving 416 horses treated with oral prednisolone compared to 
two time-matched controls per case, there was no significant difference 
between the overall laminitis incidence rate, the rate of occurrence of laminitis 
whilst receiving prednisolone, or the probability of laminitis between the two 
groups, therefore the overall conclusion was that the use of oral prednisolone 
did not increase the risk of developing laminitis (Jordan et al., 2017). There is 
no evidence to support high dose glucocorticoid therapy in critically ill patients 
that are not requiring immunosuppressive therapy and the doses of 
glucocorticoids that would be recommended in critically ill patients are much 
less than are routinely used for immunosuppressive or anti-inflammatory 
effects. In human medicine several different protocols for glucocorticoid 
administration to treat CIRCI have been recommended. The latest Cochrane 
systematic review of low-dose hydrocortisone for the treatment of septic shock 
(4268 patients) showed that corticosteroids reduced the risk of death at 28 days 
compared to a placebo. The study showed that survival benefits were better 
with lower doses of hydrocortisone (< 400 mg/day) for a longer duration (at 
least 3 days).  Side effects were hyperglycaemia and hypernatremia, but there 
was no increased risk of gastrointestinal bleeding (Annane et al., 2015). 
Administration of a continuous infusion of 200 mg of hydrocortisone/day for 5 
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days, followed by a tapering dose until day 11 is one such protocol (Keh et al., 
2016). This would equate to 0.2 mg/kg/day (based on an average 70 kg 
person). However this is still a supraphysiologic dose and results in serum 
cortisol concentrations several times higher than that achieved by ACTH 
stimulation. This dose was initially based on the maximum secretory rate of 
cortisol detected in humans following major surgery. The daily cortisol 
production rate and the pharmacokinetics of hydrocortisone have been studied 
in healthy neonatal foals and adult horses to determine the requirement of 
cortisol in healthy animals as a way to determine an appropriate dosage of 
hydrocortisone for critically ill horses (Hart, 2012). As a comparison, 
prednisolone has a glucocorticoid potency 4 times that of hydrocortisone and 
dexamethasone has a potency of 30 times that of hydrocortisone (Cuming et 
al., 2018). Therefore at a dose of 0.2 mg/kg/day of hydrocortisone a 500 kg 
dose would receive 100 mg of hydrocortisone/day, 25 mg of prednisolone/day 
or 3.3 mg/day of dexamethasone as CRI administered over a 24 hr period.  
5.5.11 Potential risk of hyperglycaemia with glucocorticoid therapy in 
horses with CIRCI 
Although there has been no serious deleterious effects of low or moderate dose 
of hydrocortisone in septic humans, hyperglycaemia was one of the observed 
consequences (Keh et al., 2016). As glucocorticoids result in elevations of 
serum glucose and insulin resistance, if glucocorticoids were to be 
administered to critically ill horses, then glucose and insulin concentrations 
should also be assessed, as pancreatic failure with relative hypoinsulinemia and 
hyperglycaemia has been detected in horses with SIRS and is associated with a 
poor prognosis (Bertin et al., 2018a) paper III. Experimentally induced 
hyperglycaemia resulted in hyperinsulinemia and subclinical laminitis (de Laat 
et al., 2012). Therefore concurrent monitoring of serum glucose and insulin 
concentrations and potentially even instigation of an insulin infusion to control 
hyperglycaemia would be advised if low-dose glucocorticoid therapy was 
instigated to treat RAI/CIRCI in critically ill horses.   
5.5.12 Limitations of this study and further work 
Major limitations of the study in addition to the lack of blood pressure 
assessment on all cases was the lack of dynamic testing to rule out PPID after 
patient recovery and the absence of histopathological examination of the 
adrenal glands of all deceased horses. Unfortunately adrenal gland autolysis 
occurs rapidly and necropsies typically occurred until 12-36 hours after death, 
therefore no useful correlations could be made between the presence of adrenal 
gland hemorrhage and necrosis and endocrinological test results. Further work 
includes correlation of direct blood pressure measurements, inflammatory 
mediators and histopathological assessment of the pituitary and adrenal glands 
of critically ill horses in relation to endocrinological test results. This may 
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allow specific determination of what an inadequate adrenal response to illness 
is and refinement of cut-off values for inadequate basal and delta-cortisol 
concentrations. Multicentre, randomized, placebo controlled clinical trials of 
the low of low-dose glucocorticoid therapy in horses diagnosed with CIRCI 
and any sick horses with inappropriately low basal or delta cortisol 
concentrations is warranted, but practically speaking it would be difficult to 
obtain sufficient numbers to achieve sufficient power without involving many 
referral hospitals.  
5.5.13 Summary of findings of project V 
Although high basal ACTH and cortisol concentrations were statistically 
higher at admission in non-survivors than survivors, and horses with ischemic 
gastrointestinal lesions had higher basal cortisol concentrations at admission 
than those without ischemic lesions, those with ischemic lesions failed to 
respond to a low-dose ACTH stimulation test. There was a large proportion of 
sick horses that had basal and delta-cortisol concentrations lower than those of 
normal horses indicating adrenal dysfunction. A subset of 12 horses that were 
identified as having adrenal dysfunction through endocrinological testing were 
ultimately diagnosed with adrenal insufficiency (RAI/CIRCI) based on their 
severity of illness, and these cases had a poor prognosis for survival. Of the 
two surviving cases and the high proportion of cases that had inappropriately 
low basal and ACTH-stimulated cortisol concentrations it is still unknown if 







This thesis contributes to the knowledge about testing adrenal function in 
foals and adult horses, in addition to the pituitary, adrenal and pancreatic 
responses to illness in hospitalized adult horses. The following specific 
conclusions can be drawn from the present work: 
 
 In healthy adult horses, administration of 0.02, 0.1, 0.25 and 0.5 µg/kg 
of cosyntropin resulted in a significant increase in serum cortisol 
concentration for all 4 doses, compared with the baseline value, by 30 
minutes after administration of cosyntropin. 
 
 In healthy adult horses, administration of cosyntropin at a dose of 0.1 
µg/kg (low-dose ACTH stimulation) resulted in maximum adrenal 
stimulation, with peak cortisol concentrations after 30 minutes. 
 
 In healthy neonatal foals, administration of 0.1, 0.25 and 0.5 µg/kg of 
cosyntropin (but not 0.02 µg/kg) resulted in a significant increase in 
serum cortisol concentration, compared with the baseline value, by 10 
minutes after administration of cosyntropin. 
 
 In healthy neonatal foals, there was no difference in the peak cortisol 
concentrations obtained after administration of 0.25 and 0.5 µg/kg of 
cosyntropin at 20 and 30 minutes, respectively.  
 
 In healthy adult horses, cosyntropin administration significantly 
increased the WBC and neutrophil counts and decreased the 
eosinophil count and the neutrophil-to-lymphocyte ratio. There was a 
doubling of the neutrophil/lymphocyte ratio compared with baseline, 
240 minutes after administration of 0.25 or 0.5 µg/kg cosyntropin. 




 In healthy neonatal foals, cosyntropin administration significantly 
decreased the lymphocyte count and increased the 
neutrophil/lymphocyte ratio. The neutrophil/lymphocyte ratio 
increased 2.4-fold at 120 minutes after administration of 0.25 µg/kg of 
cosyntropin. 
 
 Hyperinsulinemia and hyperglycaemia are common problems of 
horses with SIRS; however, horses presenting with hyperglycaemia 
and corresponding relative hypoinsulinemia (suggestive of endocrine 
pancreas dysfunction) have a worse prognosis. 
 
 A continuous rate infusion of insulin should be considered as a 
treatment for horses with hyperglycaemia and pancreatic dysfunction, 
with monitoring of serum glucose and insulin concentrations to ensure 
that hypoglycaemia or hyperinsulinemia does not occur. 
 
 In sick horses, cortisol, ACTH and ACTH/cortisol ratios were higher 
in non-survivors at admission. ACTH/cortisol ratios were higher in 
horses with SIRS and those with an ischemic lesion, suggesting 
adrenal dysfunction. 
 
 Although high basal ACTH and cortisol concentrations were 
statistically higher at admission in non-survivors than survivors, and 
horses with ischemic gastrointestinal lesions had higher basal cortisol 
concentrations at admission than those without ischemic lesions, those 
with ischemic lesions failed to respond to a low-dose ACTH 
stimulation test.  
 
 A large proportion of sick horses had basal and delta-cortisol 
concentrations lower than those of normal horses indicating adrenal 
dysfunction.  
 
 Adrenal insufficiency/CIRCI was diagnosed in 21% of sick horses 
based on endocrinological testing and the presence of critical illness 
and these cases had a poor prognosis for survival.  
 
 It is unknown if the treatment with low doses of hydrocortisone would 
improve survival rates in horses diagnosed with CIRCI, but treatment 




 It is unknown if treatment with low doses of hydrocortisone would 
improve outcome (survival or length of hospitalisation) in the high 
proportion of cases that had inappropriately low basal and ACTH-
stimulated cortisol concentrations. Further work using clinical trials is 
required to further define cut-off values for these parameters in sick 
horses and determine whether glucocorticoid therapy to at least 
normalize cortisol concentrations is beneficial. 
 
 If glucocorticoid therapy is instigated in the treatment of horses with 
inappropriately low basal or ACTH stimulated cortisol concentrations, 
then it will be important to monitor the effects on the glucose/insulin 






7.1.1 Cosyntropin pharmacokinetics  
The radioimmunoassay used to measure ACTH concentrations does not 
differentiate endogenous ACTH concentrations from exogenous ACTH 
concentrations (from the administration of synthetic ACTH = cosyntropin). The 
ACTH stimulation test is a pharmacodynamics test of cosyntropin measuring the 
duration of action of the cosyntropin by measuring cortisol concentrations over 
time. It is not possible to determine the exact duration of persistence of 
cosyntropin product, but we have analysed ACTH concentrations after the 
administration of the 0.25 µg/kg dosage of cosyntropin administered to the 8 
adult horses at each of the time points (T = 0, 30, 60, 90, 120, 180, and 240 
minutes) after injection of cosyntropin and to the 11 neonatal foals at same time 
points and also T = 10 and 20 minutes in 6 of the foals. The ACTH measured 
will be a combination of exogenous and endogenous ACTH concentrations but 
some useful information on the half-life and clearance of cosyntropin may be 
able to be extracted. We know from our pharmacodynamics work in papers I and 
II that there is some negative feedback on cortisol concentrations occurring by 
240 minutes which will be a confounding factor 
 
7.1.2 Multivariate logistic regression analysis of factors associated with 
survival including glucose, insulin, ACTH and cortisol  
The data set of 150 horses and over 40 variables is available for further potential 
analysis 
 
7 Future considerations 
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7.1.3 Immunoreactive ACTH and stability issues 
Liquid chromatography and high-resolution/high-accuracy mass spectrometry 
(LC-MS) are the gold standards to measure hormone concentrations. Although 
useful in a research setting LC-MS is not utilized for clinical cases due to the 
requirement of sophisticated equipment and specialised technical skills and the 
time involved in sample analysis. As there are no equine specific cortisol, ACTH 
or insulin standards or antibodies, all commercially available assays will likely 
underestimate equine hormones compared to LC-MC. The Scantibodies™ 
immunoradiometric kit used in the present study has been shown to be highly 
accurate, but measures 3.6-fold lower than the chemiluminescent Immulite™ 
(Schott, 2013). There is speculation that the ACTH measured by the Immulite™ 
may not all be ACTH1-39 as the two-site antibody test that was designed and  
optimised for human ACTH may be cross reacting with other equine 
proopiomelanocortin derived peptides. A study using LC-MS to compare results 
obtained with the Immulite™ and other commonly used analysers and ACTH 
kits using equine plasma from normal horses, stressed horses and ACTH from 
horses with PPID pre and post thyrotropin releasing hormone stimulation should 
be performed and we are attempting to gain funding for such a study. This may 
explain the lower values obtained from the radioimmunoassays used in the 
current study compared to results obtained in other studies using the Siemens 
Immulite™.  
    As radioimmunoassays are becoming less available, the Siemens Immulite™ 
analyzer is being frequently used to measure equine ACTH. Recent work from 
our laboratory has recommended that when using this analyzer that plasma 
samples are not frozen, kept at 4°C, centrifuged within 2 hours and analyzed 
within 8 hours of collection to prevent misdiagnosis of PPID (Bertin et al., 
2018b). Less than ideal sample handling resulted in decreases and increases in 
ACTH concentrations and thus false positive and false negative diagnoses of 
PPID. Although this may not be relevant for stress induced ACTH originating 
from the pars distalis, the instability of immunoreactive ACTH appeared to be 
worse in horses with PPID compared to normal horses. As these ideal conditions 
of sample handling can not be readily achieved in equine general practice, 
accurate measurement of equine ACTH may be relegated to a teaching hospital. 
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In response to stress from exercise or illness, adrenocorticotropic hormone 
(ACTH) is released from the pituitary gland and acts on the adrenal glands to 
increase the production and release of cortisol. Cortisol is important in sick 
patients to increase the availability of glucose for energy production; moderation 
of the immune system and also in the regulation of blood pressure. In critical 
illness the concentrations of ACTH and cortisol should be very high, therefore 
it is expected that non-surviving patients may have higher concentrations of 
ACTH and cortisol than surviving patients with less severe disease. However 
the adrenal gland can be damaged or become “exhausted” during illness and 
production of cortisol may be much lower than expected for the degree of illness. 
Therefore inappropriately low cortisol concentrations are also associated with 
non-survival in critically ill patients. In surviving patients this adrenal 
dysfunction is transient and resolved after resolution of the underlying illness. 
This condition is known as relative adrenal insufficiency (RAI), which is part f 
the larger syndrome of critical illness related corticosteroid insufficiency 
(CIRCI). The diagnosis of RAI is made based on an inappropriately low cortisol 
concentration or an inadequate adrenal production of cortisol in response to 
administration of synthetic ACTH. Diagnosis and treatment of RAI/CIRCI 
results in an increase in survival rates in critically ill humans.  
    Investigation of appropriate dosages of synthetic ACTH to diagnose RAI in 
adult horses, or even if the condition existed in critically ill horses was 
previously unknown. We determined the most appropriate dosage of synthetic 
ACTH to cause adrenal gland stimulation and release of cortisol in healthy adult 
horses and neonatal foals.  
    We then measured ACTH and cortisol concentrations in 151 sick horses and 
administered synthetic ACTH to test for adrenal dysfunction in 58 sick horses. 
As expected, we found that sick non-surviving horses had higher concentrations 
of ACTH and cortisol than surviving horses at hospital admission. However we 
also found that 45% of sick horses had low cortisol concentrations at some time 
Popular science summary 
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during the initial 6 days of hospitalisation. We also found that 67% of the sick 
horses had an inappropriately low cortisol response after the administration of 
synthetic ACTH at some time during the initial 6 days of hospitalisation. These 
findings indicate adrenal dysfunction in sick horses. Adrenal dysfunction was 
identified in 21% of the critically ill horses, and only 2 of these 12 horses 
survived. These horses were considered to have RAI/CIRCI. Many of the non-
surviving horses were euthanised due to severe intestinal damage that was not 
considered amenable to surgical repair. Treatment with low dosages of cortisone 
may be indicated in some critically ill and even some less severely sick horses 
to return concentrations of cortisol to at least that of normal horses when adrenal 
dysfunction is diagnosed. Further research is required to determine if such 
treatment will increase survival rates in critically ill horses as has occurred in 
critically ill humans. 
During illness, as a consequence of the stress response, cortisol and other 
hormones increase the availability of glucose in the blood to provide energy for 
the patient. Excessive glucose concentrations are reduced by the production of 
the hormone insulin by the pancreas. Failure to produce sufficient insulin with 
the development of abnormally high blood glucose concentrations results in 
diabetes. Insufficient insulin concentrations and the development of transient or 
permanent diabetes is a rare diagnosis in adult horses. Although never reported 
in critically ill adult horses, diabetes has been reported in one critically ill foal. 
Non-surviving sick horses often have markedly higher blood glucose 
concentrations than surviving horses, but insulin concentration had never been 
measured in sick horses prior to this work. We measured blood glucose and 
insulin concentrations in 51 horses with severe illness. Non surviving horses had 
higher glucose concentrations and lower insulin concentrations than surviving 
horses. This suggests that there is pancreatic dysfunction and a form of diabetes 
in critically ill horses.  
Excessively high blood insulin or glucose concentrations have 
experimentally been shown to result in the development of laminitis, which is 
an exceeding painful condition where the sensitive and non-sensitive structures 
of the hoof separate. Laminitis also occurs in critically ill horses and can be so 
severe that the horse must be euthanised due to the laminitis even if the 
underlying primary disease or condition has been successfully medically or 
surgically resolved. In critically ill humans, regulation of blood glucose 
concentrations by the administration of insulin has improved survival rates in 
some studies. Administration of insulin to sick horses that have high blood 
glucose and low serum insulin may be advantageous and may even prevent 
laminitis in some cases. Further research is required to confirm that such 
treatment improves survival in critically ill horses.  
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Fysiskt arbete eller sjukdom ger upphov till en stressrespons i kroppen. 
Adrenokortikotropt hormon (ACTH) släpps ut från hypofysen och påverkar 
binjuren vilket i sin tur ökar produktionen av kortisol. Kortisol har en viktig 
roll vid sjukdom för att öka tillgången på glukos för energi, samt för att 
moderera immunsvaret och reglera blodtryck. Vid allvarlig sjukdom stiger 
ACTH- och kortisolkoncentrationen kraftigt och därför borde de sjukaste, icke-
överlevande, patienterna ha högre halter av dessa ämnen än de som tillfrisknar 
igen. Det är dock så att binjuren kan bli ”utmattad” under sjukdomsprocessen 
och kortisolhalterna kan därför vara mycket lägre än förväntat med tanke på 
sjukdomens allvarlighetsgrad. Låga kortisolnivåer är därför också associerat 
med sämre överlevnad hos intensivvårdspatienter. Hos överlevande är 
binjureinsufficiensen övergående och försvinner i samband med att den 
underliggande sjukdomen avtar. Tillståndet kallas ”relative adrenal 
insufficiency” (RAI), och är en del av det mer omfattande tillståndet 
sjukdomsrelaterad sekundär kortisolsvikt (critical illness related corticosteroid 
insufficiency, CIRCI). Diagnosen RAI ställs baserat på onormalt låga 
kortisolnivåer vid sjukdom, eller genom att mäta responsen efter injektion av 
syntetiskt ACTH. Diagnos och behandling av RAI/CIRCI ökar chansen för 
överlevnad inom humanvården. 
    På hästsidan har vi tidigare saknat information om ifall samma 
sjukdomstillstånd existerar, och hur man i så fall bäst doserar ACTH för 
testning.  
    Vi fastställde lämplig dos syntetiskt ACTH för binjurestimulering och 
kortisolfrisättning hos friska hästar och neonatala föl. Därefter analyserades 
ACTH och kortisolnivåer hos 151 sjuka hästar. Sjuka hästar som inte 
överlevde hade högre nivåer av ACTH och kortisol vid ankomst till klinik än 
de som klarade av sjukdomen och överlevde. Vi fann dock att 45 % av de sjuka 
hästarna hade oväntat låga kortisolnivåer någon gång under de första 6 dagarna 
av sjukhusvistelsen. Syntetiskt ACTH gavs till 58 hästar för att testa 
binjurefunktionen. Vi upptäckte då att 68 % av dessa hade för dålig 
kortisolrespons efter injektion av syntetiskt ACTH vid något tillfälle under de 6 




hästar.  Uttalad binjureinsufficiens (RAI/CIRCI) identifierades hos 21% av 
hästarna som intensivvårdades, och endast 2 av dessa 12 hästar överlevde. 
Många av de hästar som inte klarade sig avlivades p.g.a. grava tarmskador som 
bedömdes inoperabla.  
    Behandling med låg dos kortison kan vara indicerat för en del 
intensivvårdspatienter och även för vissa mindre kritiskt sjuka hästar för att 
återställa kortisolnivåerna när binjureinsufficiens konstaterats. Fler studier 
behövs för att fastställa om sådan behandling kan förbättra överlevnaden för 
akut sjuka hästar på samma sätt som det gjort på humansidan. 
    Vid sjukdom bidrar stressresponsen till att kortisol och andra hormon frigör 
mer glukos för att bidra med energi. Insulin frisätts från bukspottkörteln för 
reglera att blodglukosnivåerna inte blir för höga. Om otillräcklig mängd insulin 
produceras, kommer detta att resultera i kraftigt förhöjda glukosnivåer och 
diabetes. Detta tillstånd är ovanligt och har aldrig rapporterats hos akut sjuka 
vuxna hästar, men har rapporterats hos ett kritiskt sjukt föl.  
    Icke-överlevande sjuka hästar har ofta markant högre blodglukosnivåer än 
överlevande, men insulinnivåer har inte tidigare utvärderats hos sjuka hästar. 
Vi analyserade blodglukos och insulinnivåer hos 51 gravt sjuka hästar. Icke-
överlevande hade högre glukoskoncentrationer och lägre insulinnivåer än 
överlevande hästar.  Detta indikerar att riktigt sjuka hästar kan ha nedsatt 
funktion av bukspottkörteln och i och med detta en typ av diabetes.  
     Överdrivet höga halter av insulin eller glukos i blodet har experimentellt 
visats kunna leda till fång, en mycket smärtsam sjukdom med separation av 
lamellerna i hovväggen. Fång är också en allvarlig komplikation hos kritiskt 
sjuka hästar och kan i vissa fall bli så problematisk att den i sig leder till 
avlivning trots att den underliggande sjukdomen kunnat behandlas. Inom 
humanvården har man i vissa studier visat på förbättrad överlevnad när man 
aktivt kontrollerat blodglukosnivåer genom att tillföra insulin. Det kan vara så 
att tillförsel av insulin till hästar med förhöjt blodglukos skulle kunna vara 
fördelaktigt och förebygga fång i vissa fall. Vidare studier krävs för att 
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If you would like your horse included in the study, please sign the following 
statement. 
Appendix 1. Information for clients regarding study 
enrolment 
Dear horse owner, 
 
As part of a study to eventually help critically ill horses we are measuring 
some of the naturally released stress hormones that are released in times of 
illness. During stressful events (exercise, transportation and illness) the body 
increases its production of the hormones cortisol and ACTH (the substance that 
causes the release of cortisol). Information from human intensive care patients 
indicates that during times of very severe illness, the body’s supply of natural 
cortisol and ACTH is inappropriately low. It appears that supplemental therapy 
to supply cortisol improves survival rates for critically ill humans. 
Unfortunately, little is known about the effects of severe illness on cortisol 
and ACTH concentrations and release in horses. Recognition of inadequate 
cortisol and ACTH release may help identify individual horses that may benefit 
from low-level cortisol treatment.    
At Auburn University, we are proud to be at the forefront of equine 
intensive care.   We wish to gather information about cortisol and ACTH levels 
in the sickest horses that are treated at the John Thomas Vaughan Large 
Animal Clinic (JTVLAC). Publishing our findings may assist countless other 
critically ill horses worldwide. 
We would like to offer your horse an increased level of intensive care 
monitoring by measuring his/her cortisol and ACTH concentrations. 
Unfortunately, results may not be immediately available, but the results from 
your horse may eventually help other horses.  
 We would like to collect an additional 27 mls of blood (at the same time 
that routine bloodwork is performed) and perform an ACTH stimulation test on 
four occasions. The ACTH stimulation test is extremely safe and is routinely 
performed in human intensive care patients. The ACTH test has been 
performed in normal and exercising horses and premature foals without any 
side-effects. The collection of the blood and the analysis of blood results will 
not affect the treatment that your horse will receive.  
 
In order to collect blood and record your horse’s results in our study, we 
must obtain your written permission. The additional testing will be 
performed free of charge. We hope to eventually publish the results of our 
study, but your name and your horse’s name and details will remain 
confidential. The results of our study may enhance the care of future 
generations of equine patients.   
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Appendix 2. Client consent form for use of client 
owned horses from Auburn University for 
Identification of Relative Adrenal Insufficiency in 
Critically Ill Adult Horses and Neonatal Foals 
I     give permission 
for an additional 27 mls of blood to be drawn from my horse at admission and 
then every 2 days on 3 more occasions, at the same time that routine 
bloodwork monitoring is performed during the period of hospitalisation. I also 
give permission for an ACTH stimulation test to be performed on 4 occasions, 
which involves the collection of an additional 10 mls of blood after the 
administration of a small dose of ACTH. I understand that the cost of ACTH is 
expensive, but this additional testing will be performed free of charge. This 
study will also pay for my routine bloodwork on 2 occasions, which will be 
discounted from my bill. I understand that this additional monitoring will in no 
way affect the quality or type of care my horse will receive. I also understand 
that to have been chosen to be included in this study that my horse is extremely 
sick, and I am responsible for the payment of the care that he/she requires 
regardless of the outcome.  
 
Signed:  Date:   
 
Print:      
 
Phone:                          Fax:           
 
Horse’s name:  Case Number:   
 
Age:   Breed: Sex:  
 
My veterinarians’ name: Phone:    
Thank-you for your participation in this study. At Auburn University 
we are committed to offer the best in equine intensive care. We also hope that 
we can contribute scientific knowledge that may be of benefit to horses 
worldwide. Auburn University is committed to excellence in teaching, research 
and outreach, and at the JT Vaughan Large Animal Hospital faculty and staff 
will strive to provide the ultimate in intensive care, 
Yours sincerely,  
 
Allison Stewart BVSc(Hons), MS, Diplomate American College of Veterinary 
Internal Medicine, Fellow in Veterinary Emergency and Critical Car 
  
 
 
